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In 1872 George Huntington described an illness characterized by chorea and psychiatric 
symptoms with a hereditary nature. This illness is since called Huntington’s chorea 
and in the eighties of the last century Huntington’s disease (HD).1 Huntington’s disease 
is characterized by a triad of psychiatric, motor and cognitive symptoms. In clinical 
practice most patients are diagnosed when motor symptoms appear, although the other 
symptoms may precede. The genetic mutation that causes HD was discovered in 1993 and 
since then predictive testing with a theoretical 100% accuracy is possible. The HTT gene 
defect, an elongated CAG repeat, is localized on chromosome 4.2 Huntington’s disease is 
a neurodegenerative disorder and is autosomal dominantly inherited. This means every 
child of an affected parent has a 50% chance of inheriting the gene and thus the disease. 
The option of predictive testing for HD by direct mutation analysis has been available 
for at-risk individuals since the CAG repeat expansion was identified. Main reasons for 
requesting the test are relief from uncertainty and planning for the future, with the 
inclusion of exerting control over the end stages of the disease. Uptake of predictive 
testing is consistently reported in between 5% and 25% of individuals at risk. Next to 
predictive testing, prenatal or preimplantation genetic diagnosis for HD is available in The 
Netherlands.3
Symptoms and signs of HD typically become manifest between the age of 30 and 50, 
affecting relatively young people, who usually still have a job and a young family. Disease 
duration is approximately 17-20 years. All patients will become totally dependent for all 
daily life activity and usually need nursing home care during the last couple of years.4;5
The existence of the disease within families, usually over many generations, has resulted 
in extensive knowledge of the course of the disease for family members at risk. After 
predictive testing or clinical diagnosis many patients know what to expect in the future. 
This knowledge and the possibilities to make choices and the need for control regarding 
the end of life, including the options of euthanasia and physician assisted suicide (PAS), 
resulted in an increased awareness amongst patients with HD, their family members and 
physicians that this is an increasingly important topic. 
Termination of Life on Request and Assisted Suicide Act in The Netherlands 
The debate about euthanasia started in the 1970s when awareness in society grew that 
sometimes physicians support patients in the dying process.6 During that same period 
important political developments had taken place. The Royal Dutch Medical Association 
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(KNMG) was asked about their opinion on euthanasia along with several other 
organizations. The KNMG did not take a position for or against euthanasia but propagated 
the view that the medical profession was prepared to take responsibility for euthanasia.6
In 2002 the process resulted in the “Termination of Life on Request and Assisted Suicide 
Act”, which codified the requirements of due care and made the Regional Review 
Committees (RRCs) principally responsible for reviewing reported cases.6
Table 1.1 The requirements of due care 
1 The physician is convinced that the patient’s request was voluntary and well considered
2 The physicians in convinced that the patient’s suffering was unbearable and there was no prospect 
of improvement
3 The physician informed the patient about his situation and prospects
4 The physician and patient were convinced that there was no reasonable alternative in light of the 
patient’s situation
4 The physician consulted at least one other, independent physician, who must have seen the patient 
and given a written opinion on the requirements of due care
5 The physician terminated the patient’s life or provided assistance with suicide with due medical care 
and attention
Since the codification, euthanasia and PAS have been subject of ongoing political and 
societal debate. Nevertheless in the course of these almost 30 years the public opinion 
also evolved to the point that a good 90% of the population is not against the legalization 
of euthanasia.6 
Since the law of 2002 passed each year more reports on euthanasia and/or PAS are 
reported to the RRCs (Figure 1.1).7 In 2012 4,188 persons died as a result f euthanasia or 
PAS, which represent approximately 3% of all deaths in The Netherlands.7;8
The possibility of euthanasia based on an advance directive is codified in article 2, 
paragraph 2 of the law. This paragraph of the law states that in case of an advance 
directive, the advance directive can replace the direct (oral) request for euthanasia. In this 
case the other requirements of due care are accordingly applicable and should be met. 
From 2008 and onwards the RRCs received reports of euthanasia in case of dementia. 
Common policy of the RRCs is to handle these reported cases with care and caution, 
because of the nature of the disease, the nature of the request and the consequences of 
the request.7 
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End of life clinics
With an increased attention for the possibilities of euthanasia based on an advance 
directives and in case of dementia, the debate seems to shift towards having end-of-
life wishes and the value of advance directives in neurodegenerative diseases, such 
as Alzheimer’s disease or Huntington`s disease especially in advanced stages of these 
diseases.9;10
The increased attention has come to a new peak in The Netherlands with the 
establishment of end-of-life clinics in 2012. The aim of these clinics was to enable 
patients, who could not find their own physician willing to perform euthanasia or PAS, to 
die peacefully as a result of euthanasia or PAS, on the condition that the patient fulfills all 
the requirements of due care of the Euthanasia Act. These clinics consist of specialized 
teams of a physician and a nurse. First, members of the clinic perform an assessment 
on paper and decide if the request seems legitimate. If a request seems legitimate and 
feasible a team further investigates the request and contacts the patient. The team 
then decides if the request meets the requirements of due care according to the law. 
In the first 18 months since the advent of the clinics (in August 2013) 1,064 patients 
approached the end-of-life clinic in order to ask for euthanasia or PAS. About 10 percent 
of the patients died as a result of euthanasia, administered by a team from the clinic; 
another almost 10% found their general practitioner willing to perform the euthanasia in 
the end, usually after mediation of a team of the clinic. Furthermore, about 10% of the 
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patients decided to withdraw their request. Fifteen percent of patients died before the 
request could be further investigated or fulfilled and about 23% of patients await the help 
of the teams of the end-of-life clinics. In 29 percent of cases the request was denied by 
the clinic, for two main reasons. One reason was administrative, for example the refusal 
of the patient to obtain his medical file with his/her treating physicians and the second 
reason was that the medical team of the clinic could not perform euthanasia or PAS 
because the patient did not meet all the requirements of due care.11
Termination of Life on Request or Assisted Suicide Acts: world wide
An increased attention for the topic of euthanasia and assisted suicide emerged in other 
countries as well. End-of-life wishes became part of the debate in health care and part 
of the debate about determining and keeping quality of life. This attention resulted in 
legislation in some countries in respond to the increased questions from patients, families 
and health care workers.6 
First attempts to come to codification of the subject of euthanasia and PAS were done 
in Oregon, USA in 1994. In 1994 a law passed making PAS legal, but euthanasia illegal. 
The law became effective in 1997 due to legal challenges. PAS is allowed in case of a 
terminal illness, when a patient is older than 18 and has less than 6 months to live. A 
written request must be present, signed by two witnesses. In 2008 and 2009 two other 
States, Washington and Montana, legalized physician assisted suicide. Euthanasia is still 
considered a crime.12;13 
In Switzerland assisted suicide has been legal since 1918. The law does not require 
assistance from a physician and motives for the law were not primarily medical.12;13 
In Belgium studies showed that euthanasia and PAS were executed without judicial 
confirmation. For this reason in 2002 the Belgian parliament enacted a law to legalize 
euthanasia and PAS, either after a direct request or based on an advance directive, after 
the requirements of due care have been met.6 
The last country to legalize euthanasia in recent history was Luxemburg. Although the law 
had been in preparation for many years, it was not until 2009 that parliament passed the 
law. The delay was incurred by the refusal of the grand duke of Luxemburg, based on his 
religious beliefs, to sign the law. In response parliament took away some of the powers of 
the grand duke, making it not necessary anymore that the grand duke should sign all laws. 
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Nowadays terminally ill patients can request euthanasia after consent of two physicians 
and a panel of experts. Other requirements of due care resemble those required in The 
Netherlands.14
Aims of this thesis and research questions
Most patients in The Netherlands will discuss their wishes for the end of life with their 
general practitioner, but for HD patients, both nursing home physicians and medical 
specialists, neurologists and psychiatrists, will be involved early during their disease 
course and thus in a conversation about the subject of wishes for the end of life. Clinical 
experience learns that patients with HD and identified mutation carriers show interest 
in the options of euthanasia and PAS. We observed in our out-patient clinic that an 
increasing number of patients brought the subject under the attention of the physician. 
Therefore, we wished to investigate what, how and when this was actually the case.
In the first chapter we investigated the theoretical option of euthanasia in HD, after a 
direct request or based on an advance directive (chapter 2).
To investigate whether HD patients or identified mutation carriers actually have end-
of-life thoughts or wishes and whether they are willing to talk about these wishes we 
conducted two studies, one qualitative and one quantitative study. If end-of-life thoughts 
and wishes are present, we wanted to explore the content of these wishes and whether 
a patient seeks information or finds out how to have these wishes documented and 
respected. Secondly we want to study whether there actually is an increase in questions 
and deliberations concerning these issues (chapter 3 and 4). 
We also wanted to study the perspective of physicians when talking and thinking about 
euthanasia and/or PAS in case of HD. Do physicians actually discuss this topic more often 
and do they receive questions concerning the topic of end-of-life wishes, both in The 
Netherlands and other European countries and how do physicians cope with and react to 
these kinds of questions from HD patients (chapter 5, 6 and 7). 
In the final chapter (chapter 8) the principal results of this thesis are put together. 
They provide a starting point for both physicians treating patients with other 
neurodegenerative diseases and patients suffering from these diseases to enhance 
treatment and seek for the possibility to not only talk about quality of life, but when 
talking about quality of life in such a case, also about quality of dying.
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Euthanasia or physician-assisted suicide is increasingly considered by patients 
with Huntington’s disease and identified gene carriers in The Netherlands. After 
codification of the Euthanasia Act in 2002 euthanasia performed by a physician is 
legal under strict conditions after a direct request from a competent patient and/
or on the basis of an advance directive. In the absence of any effective treatment 
for Huntington’s disease euthanasia or physician-assisted suicide can be an option 
for patients. The clinical, ethical and legal dilemmas associated with euthanasia or 
physician-assisted suicide in Huntington’s disease are discussed.
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IntroductIon
Huntington’s disease (HD) is a progressive neurodegenerative disease, caused by an 
autosomal dominant inherited expansion of a CAG-repeat on chromosome 4, known as 
the huntingtin gene. The disease is characterised by chorea and hypokinesia, psychiatric 
symptoms and progressive cognitive decline leading to dementia. The onset of disease is 
usually between 30 and 50 years of age.1 The duration of illness is between 10-20 years. 
The rate of suicide is higher compared to the general population.2 Currently symptomatic 
treatment to alleviate the symptoms and signs is available, but there is no cure for this 
devastating disease. Because the disease is progressive, all patients eventually will 
become totally dependent for all daily life functions.3 
The localization of the genetic cause in 19834 and the identification of the HD-gene in 
1993 made premanifest DNA testing possible in individuals at risk.5 Testing is performed 
after extensive information about the procedure and possible consequences according to 
internationally agreed guidelines.1
In the Netherlands the codification of the Euthanasia Act in 2002 made euthanasia legal 
under strict conditions. The public debate on the subject of euthanasia and dementia 
started in the early nineties and has been going on since then.6 The law of 2002 regulated 
part of the subject, but did not end the debate.7 The number of cases reported to 
the committee increased from 1815 in 2003 to 2636 in 2009.8 Most (85%) euthanasia 
requests concern patients suffering from cancer. In the group of diseases of the nervous 
system most patients requesting euthanasia suffer from Amyotrophic Lateral Sclerosis 
(ALS) about which extensive research has been done.9
There are substantial differences between ALS and HD when considering end-of-life 
issues, which differences also apply to other neurodegenerative diseases. The mean 
duration of illness in ALS is 3 years, whereas in HD and most other neurodegenerative 
diseases the duration is much longer, over 15 years. A second difference is that cognition 
remains rather intact in ALS in contrary to HD and other neurodegenerative diseases. 
And a third argument is the fact that many HD patients and mutation carriers are 
knowledgeable of the characteristics and the course of the disease in the affected parent 
or other family members.
Besides clinical experience and anecdotal data there are no studies on euthanasia or 
physician assisted suicide (PAS) or other end-of-life questions in patients with HD. Some 
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research has been done on euthanasia and advance directives in dementia in recent years 
in the Netherlands.10 Considering the arguments mentioned above this is a field where 
research is warranted. In this article we search for the possibility of euthanasia or PAS and 
the role of advance directives in HD. This paper may serve the debate on euthanasia and 
PAS in HD. 
suIcIde
After pneumonia suicide is the second most common cause of death in HD.1 Two periods 
have been identified in which the risk for suicide is increased in HD. The first period is 
immediately before receiving a formal diagnosis of HD and the second period is when 
independence diminishes and symptoms and signs of the disease increase.11
Subtle cognitive deficits are present in pre-manifest patients. Also a higher prevalence 
of psychiatric disorders (depression and obsessive-compulsive disorder) in pre-manifest 
mutation carriers has been described compared to the general population.12 Both 
symptoms might result in impaired judgement. Therefore one can speculate that suicide 
ideation could be classified as a psychiatric disorder, which is part of the signs of HD. But 
on the other hand the Dutch Association of Psychiatry stated in their guideline “Dealing 
with the request for euthanasia and/or PAS” that suicide is not always a sign of psycho-
pathology.13 When evaluating these two considerations on suicidal ideation, suicide can 
also be a well considered option for a patient or pre-manifest gene carrier to prevent 
deterioration and future dependence.13 Similar motives have been mentioned in earlier 
research on reasons for euthanasia in elderly.14
short recAll on the development of the 
euthAnAsIA debAte In the netherlAnds
Until the 1970s euthanasia and PAS were not debated in public in the Netherlands. The 
Penal Code holds killing as an offence, including killing on request or assisting suicide 
(Article 293 Penal Code). 
In the 1970s these opinions slowly start to change when in Dutch society the awareness 
arrived that sometimes doctors support patients in the dying process. The word 
euthanasia enters the discussion, but the scope of the concept had yet to be determined.6
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In the late 1980s it was decided that only active termination of life at the patients request 
is regarded as euthanasia in the Netherlands. In that same period euthanasia becomes 
accepted if performed by a physician under strict circumstances defined by courts and the 
Royal Dutch Medical Association. An effort to codify this practice had failed until 2002. 
The first euthanasia case to reach the Supreme Court was the case of Dr. Schoonheim 
(Table 2.1). This was the first time a physician was not found guilty after performing 
euthanasia.15 In the following decade more cases were brought into court and the first 
steps towards codification were set.
euthAnAsIA Act In the netherlAnds
In the Netherlands the Euthanasia Act was approved by parliament in 2002. The law holds 
euthanasia and PAS as a criminal offence unless they are performed by a physician who 
acts according to six criteria and reports the case to a review committee (Table 2.2).
Regarding HD, physicians can encounter several problems when fulfilling these criteria 
for euthanasia or PAS. The six criteria are discussed below separately to see how they can 
apply to HD.
table 2.2 Six criteria of care for euthanasia6 
1 Request was voluntary and well considered.
2 Suffering was unbearable and without prospect or relief.
3 Patient must be informed about the situation and prospects.
4 No alternative solution for the situation.
5 One other physician must have seen the patient and given a written evaluation.
6 Ending of life must be performed professional and careful.
table 2.1 Schoonheim case 
In this case the general practitioner (GP) Schoonheim had performed euthanasia on a 95-year-old 
female who on several occasions had asked him to end her life. The patient was bedridden after a hip 
fracture and had deteriorating eyesight and hearing. Mentally she was in full possession of her capacities. 
After deliberating with the patient and her family, the GP acceded to her request. The Supreme Court 
considered that this situation could be a situation of necessity. The Court referred to the patient’s 
unbearable suffering, the prospect of loss of personal dignity and to die in a dignified manner. The Court of 
Appeals then accepted his defence of necessity and acquitted the GP.
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Explore the request from the patient, for the future or present time
Advance directives
The introduction of the Euthanasia Act in The Netherlands made it possible to replace a 
request for euthanasia or PAS, which is intended to be executed in the near future, by an 
advance directive, which is intended to be executed in the future, as long as the other 
requirements are met. Now a competent patient can make a request in advance, to be 
executed when the patient becomes incompetent and loses his decision making capacities. 
With an advance directive patient’s autonomy is respected and extended into the future.16
But an advance directive, like an oral request for euthanasia is not a right, but a request, 
without binding legal consequences.6
Although advance directives for euthanasia were originally largely intended to apply to 
patients with dementia, the validity of these advance directives is now debated in case of 
patients with dementia.6;17 In patients with dementia the gradual progression allows them 
to adapt to the disease. This can make patients deviate from their anticipatory beliefs, 
called response shift.16
Decline or complete absence of disease-insight can be the cause of a change of opinion 
and patients can contradict their own advance directive.7 Also patients can find it difficult 
to decide and specifically articulate in advance what the wishes will be. And when 
documenting the wishes, patients may not want to opt out future developments, for 
example new treatments or family circumstances.18
Thirdly Dutch studies on dementia and euthanasia showed that physicians aren’t very 
inclined to follow the advance directive, because they think it is invalid or even illegal, the 
advance directive was not explicit enough or think euthanasia for a patient with dementia 
is unacceptable.10;19
But there is a difference between HD and patients with dementia regarding advance 
directives. Unlike dementia patients with HD usually know of the existence of HD in the 
family. Because most patients have had experience with HD they also usually have had 
many years to think about end of life, which can include euthanasia or PAS. 
The elements of response shift, the accuracy of the will, future development in treatment 
and increasing incompetence make the draft of an advance directive difficult. But because 
of the knowledge of symptoms and signs, advance directives can be a good way of 
documenting at least the present will in HD.7 
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The premanifest or early manifest phase of the disease
Once identified as gene carrier, individuals may have profound thoughts and worries 
about their future quality of life. For gene carriers in pre-manifest phase in our clinic we 
have observed an increase in conversations about end-of-life wishes, as part of their wish 
to exert more control over their future life. It is a challenge for the physician to seriously 
and empathically respond to the thoughts and wishes regarding end-of-life decisions. In 
this stage decision making capacities and competence are not affected yet. The physician 
has a task exploring the request when the patient discusses the advance directive. He has 
to be sure it is voluntary and well considered (Table 2.3).20 
table 2.3 Recommendations to assess decision making capacity 
1 Be able to choose and express the choice.
2 Be able to understand relevant information.
3 Be able to reason about the situation and its possible consequences and to appreciate these 
consequences.
4 Be able to handle the information rationally and value it according to own morals and values.
The manifest phase
If the patient is in the advanced stage of the disease competence and decision making 
capacity is often a problem. There will usually be a diminished understanding and 
reasoning and expression of the will can lack consistency. The cognitive deterioration may 
be differently valued if the will is expressed to the physician for a longer period of time or 
has just recently been expressed.6 
While exploring the medical decision making capacity studies have shown that patients 
with mild cognitive impairment already have a diminished understanding (of the 
information), reasoning about the situation, the choice and possible consequences.21
Although a recent study emphasizes that communication with elderly with dementia is in 
the early stages quite possible and essential for advance care planning to be adjusted to 
their actual wishes and needs.22 
The decision making capacity and competency is assessed for the decision at hand and 
not for capacity and competence in general and must be distinguished from having 
a will.20 There is still debate about whether the requested level of decision making 
capacity and competence of a patient depends on the gravity of the consequences of 
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the decision. Most doctors feel that the graver the consequence, the more competence 
needed. But this view must be balanced against respecting patient autonomy.23 For this 
reason different authors stated that it is not the solution that matters, but the way the 
patient comes to that solution.24 In the case of Schoonheim the judiciary stated that 
when considering a request for euthanasia or PAS the physician has to take personality, 
intelligence and history of the patient into account.15
Suffering 
The second criterion in the Dutch Euthanasia Act poses merely definition differences. 
Communication seems essential to the assessment of suffering. But suffering is mainly 
psychological and is a subjective experience.6;25
In the pre- and early manifest phases of HD the suffering is not physical, but is mostly 
psychological and concerns the fear of future suffering due to loss of independence and 
dignity and change of personality. This fear is realistic and can be seen as unbearable 
suffering without prospect. The legislator saw ‘without prospect’ as when there are no 
adequate alternative management options for the disease, i.e. there are no ways to 
relieve, ease or undo the suffering.25 Also after the hearing of Schoonheim, the court 
ruled that “the prospect of unbearable suffering, progressive deterioration and when 
knowing that dying with dignity is possible now, but most likely not in the future can 
qualify as suffering, taken the history, intelligence and personality of the patient into 
account.”15
In early manifest patients, symptoms such as depression or anxiety can be alleviated with 
medication to some extent. In the advanced stages the fear may have become reality. HD 
patients suffer from the decline in all functions in life, socially, professionally, and loosing 
independence, and often with full awareness.10 Studies with patients in the early stages 
of AD showed that patients are aware of their failing memory and are trying to find a way 
to cope with the problem. If these strategies work, chances of requests for euthanasia 
diminish and it is not sure if patients see their situation as suffering.19;26 This is mainly part 
of the declining cognitive functioning and with that the decline of realization of cognitive 
deficits, the lack of awareness of being ill.27 
But where in dementia the decline in cognitive functioning is the key aspect of the 
disease, in HD sometimes physical (marked hypokinesia and chorea) and psychiatric 
symptoms and signs precede the cognitive decline. In patients who encounter this course 
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of the disease, the awareness of these signs and symptoms can be very present to them, 
and coping can be very difficult because there are little means to effectively treat these. 
For this reason HD patients can continue to see their situation as suffering and be aware 
of being ill. In this group chance of diminishing requests for euthanasia seem smaller. 
Information about situation and prospects
When considering euthanasia or PAS a physician is obligated to inform the patient about 
his situation, the possibilities of treatment and prognosis.6 The information must be given 
at a time the patient is still competent and able to understand the information. Because 
HD is genetic and inherited, many have seen family members with HD and their signs and 
symptoms. Therefore patients may have had extensive information from other sources 
than their physician.28 
Alternative solutions
Pharmacological treatment allows alleviation of some of the symptoms and signs of HD, 
for example psychiatric signs and chorea. However the medication will not totally control 
the symptoms and signs which will become worse in due course.
In addition in the Netherlands chain care has been set up for HD patients. The chain care 
aims to take care of the patient from predictive testing until admittance to a nursing 
home. Even though admittance to a nursing home can give stability and symptoms can be 
relieved, it does not always provide a definite or desired solution for every patient. When 
offering chain care as an alternative solution it is important that the physician explores 
the frame of reference of his patient. Because relatives were usually taken care of in a 
different time with the absence of appropriate care it is possible that their reference is 
not up to date. The development of chain care shows that progress in HD care is made.
Statements preceding the euthanasia act stated that the alternative solution must be 
sought after extensive communication between physician and patient. There was no set 
time for this communication, so it can take place before the euthanasia request becomes 
pressing.7 The decision to opt for euthanasia is a joint conclusion between physician 
and patient that for this problem, these symptoms there is no other solution left than 
euthanasia.27 It is important as mentioned earlier to review the conclusions on a regular 
basis. A recent study emphasizes that communication with elderly with AD is in the early 
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stages quite possible and essential for advance care planning to be adjusted to their 
actual wishes and needs.
Consultation by an independent physician
In The Netherlands a system called Support and Consultation in Euthanasia in the 
Netherlands (SCEN) is available for consultation in euthanasia or PAS questions. These 
physicians are usually general practitioners (GP), are independent, specially trained, and 
available 7 days a week for consultation.29 The consultation of an independent physician is 
obligatory and SCEN offers a network that meets the requirements.
ending of life is performed professionally and carefully
There are protocols in which way to perform euthanasia or PAS. Especially regarding 
the medication used and the obligatory presence of a physician in the case of PAS 
this sometimes leads to problems. This is mostly due to a lack of knowledge with the 
physician.29
AnAlySIS And dISCuSSIon, prACtICE of EuthAnASIA
In the Netherlands between 2007 and January 2011 a total of 30 HD patients died by 
euthanasia or PAS.30 With an overall prevalence of 1/10,000 in the Netherlands there will 
be approximately 1,700 patients, and with a duration of illness of approximately 15 years, 
100 patients will die each year and a 100 new patients will get a diagnosis of HD.1 This 
means that, when approximately 7 patients die of euthanasia each year, 7% of patients 
suffering from HD die of euthanasia or PAS. In our clinic the number of requests from 
HD patients for euthanasia or PAS and advance directives concerning this issue seems 
increasing. This observation can either be a real increase or an increased awareness and 
interest in these issues and this observation can also reflect that both physicians and their 
patients are more willing and open to discuss end-of-life issues.
To date no case of euthanasia in a person with dementia based on an advance directive 
has been reported. In 2006 54% of physicians in the Netherlands said they will not 
perform euthanasia based on an advance directive in a patient with AD.10 Rurup et 
al. found also that a large percentage of physicians in the Netherlands aren’t familiar 
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with the rules regarding euthanasia, and if they are familiar there are difficulties with 
interpretation of these rules.10 
In 2009 one case of euthanasia based on an advance directive was performed on a 
patient suffering from severe aphasia. In the years before the patient and physician 
spoke frequently and extensively about euthanasia and under which circumstances 
the patient would feel that he was suffering to such an extent that euthanasia was 
considered an option. The advance directive was clear and the frequent conversations 
with the physician made that the physician was very well informed about the wishes 
of the patient. Euthanasia was performed and declared accurate and careful by the 
regional review committee. The physician stated that not performing euthanasia would 
be abandoning the patient. It would be disrespecting patient autonomy to leave him in a 
situation he wished to avoid and which he considered as unbearable suffering.8 
This line of reasoning of the physician and the acceptance by the regional review 
committee provides a clear example of the possibilities of euthanasia or PAS in HD. 
Especially the pre-manifest phase can be appropriate for physician and patient to explore 
and articulate the wishes and draw an advance directive. As we can deduct from the 
arguments mentioned before in the discussion of the criteria, the option for euthanasia 
or PAS in HD is within the scope of the law. 
Further clinical knowledge is needed to find the reasons for asking for euthanasia by 
the patient and knowing the reasons for performing or not performing euthanasia as a 
physician. Also further clinical knowledge is needed to determine the role of advance 
directives.
When there is no cure and there are little means to treat and/or diminish suffering, 
discussing end-of-life wishes can also be a way of guidance and treatment of your patient. 
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background: In the literature there are few reports on euthanasia or physician-
assisted suicide (PAS) or other matters concerning the end-of-life in patients with 
Huntington`s disease (HD), although clinical experience suggests these issues do 
arise. 
Objective: To obtain in-depth information about patients’ thoughts on and attitudes 
to euthanasia, PAS and the use of advance directives in HD. To assess the difficulties 
patients encounter when thinking about end-of-life wishes. 
Methods: Semi-structured in-depth interviews with 14 unselected HD patients from 
our out-patient clinic based on a topic list. Qualitative analysis of the interviews 
based on grounded theory.
results: We identified three patterns in our group of respondents: patients with 
distinct wishes, with general wishes and ideas and patients with no wishes. The 
most important frame of reference regarding end-of-life wishes in HD patients or 
known gene carriers is the experience with an affected parent. Family is important 
when thinking about the end of life and advance directives, even more so than the 
patient’s physician. Knowledge about the (requirements of) law is limited. 
conclusions: The majority of interviewees expressed some kind of wish regarding 
end of life, probably more than they had revealed to their physician, but were 
sometimes hesitant to discuss it. Knowledge on how to deal with wishes, advance 
directives and response shift is limited. In general, patients underestimate the 
requirement for sound professional support when considering euthanasia or PAS 
and the value of an advance directive. In an attempt to improve knowledge and 
communication about end-of-life issues, physicians should ask the patient directly 
about their wishes.
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IntrOductIOn
Huntington’s disease (HD) is an autosomal dominant progressive neurodegenerative 
disease, characterised by chorea and hypokinesia, psychiatric symptoms and 
progressive cognitive decline leading to dementia.1 To determine if a patient carries the 
HD-gene DNA-testing can be performed, either in the premanifest or manifest phase. 
There is no cure and all patients will eventually become totally dependent for all daily 
life activities. The primary cause of death is pneumonia, the second cause is suicide,1-3 
the rate being 5-12 times higher in the HD population than in the general population.3-5 
Prevalence in The Netherlands is approximately 1,700 patients; some 5,000-8,000 
persons are at risk. 
Euthanasia or physician assisted suicide (PAS) has been legal in The Netherlands, albeit 
under strict conditions, since the euthanasia act was approved by parliament in 2002. 
Approximately 7% of Dutch inhabitants have an advance directive, usually a euthanasia 
request.6;7 This document is not a patient’s right, nor is it part of normal medical 
treatment. It is a request, not a binding contract with legal consequences.8
In 2011, approx. 2.5% (n=3,695) of all deaths in The Netherlands were the result of 
euthanasia or PAS; in approx. 85% the underlying disease was cancer.9;10 The reason for 
most people in the Netherlands creating an advance euthanasia directive is to make 
arrangements in case dementia develops.6 Symptoms and signs leading to a euthanasia 
request in Amyotrophic Lateral Sclerosis (ALS) were dependency, being limited in 
communication and anxiety, whereas in cancer patients the reasons were pain and 
fatigue.11;12 In 2005, about 8,400 requests for euthanasia were made, 2,400 of which were 
granted. Several situations arise for non-performance: the patient dies before euthanasia 
is granted, in 13% of the cases the request was withdrawn and 12% of the unperformed 
requests were refused by a physician.13;14 According to physicians the most debated and 
difficult requirement of the law on the basis of which the request should be judged is the 
requirement of unbearable suffering, which has subjective aspects.15 
In The Netherlands, between six and ten euthanasia requests from patients with HD were 
granted each year between 2007 and 2011.10 Besides anecdotal reports there are few 
studies on euthanasia or PAS or other end-of-life questions and the content of wishes for 
the end of life in patients with HD. HD differs from ALS and cancer with regard to disease 
duration and cognition. A third difference is that many HD patients and mutation carriers 
know the characteristics and the course of the disease from a family member and thus 
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have a precise idea of what their future will be like, usually at a much earlier stage than 
patients with other diseases. 
With an increasing prevalence of neurodegenerative diseases and usually limited 
treatment options, the possibility of deciding the time of one’s death by euthanasia or 
PAS could be a subject of interest for expanding treatment or guidance options. This study 
therefore aimed at gaining insight into the thoughts and attitudes of patients regarding 
end-of-life issues and the use of advance directives. We also examined which difficulties 
patients experience when thinking about end-of-life wishes.
MEtHOds
Participants
All patients who visited our out-patient clinic in the first half of April 2011 (n=19) were 
asked to participate in an interview about their end-of-life wishes; 14 consented. The 
reasons for declining were for four patients 1) “Life is perfect at the moment” or “I do 
not have any wishes because I take life as it comes”, 2) for one patient the reason was a 
recently developed depression. 
Interview procedure and data analysis
Semi-structured interviews were conducted. We interviewed the patients in their home 
or in our out-patient clinic. The study was based on grounded theory.16 Initial interview 
topics were formulated after examination of the relevant literature. Consistent with 
standard qualitative research techniques, the interviews were based on a topic list, which 
evolved as the interviews progressed through an iterative process to ensure that the 
questions captured all relevant emerging themes. The interviews focused on thoughts 
and attitudes towards the end of life, the presence of advance directives, the experiences 
with HD in the family, and conversations about end-of-life wishes with either family 
members or a physician. Thematic saturation was reached after the 12th interview.17 All 
interviews were performed by the first author (SB) and took approximately one hour 
to complete. All interviews were recorded and transcribed verbatim. As our study was 
explorative, we used open coding. The transcripts were read and categorised into similar 
subject areas using inductive coding by SB and VR. Examples of codes are illness and 
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experiences in the past, importance of family and the role of a general practitioner, 




The patients ranged in age from 28 to 70 years; eight participants were female. Five 
patients went to a day-care facility or lived in a nursing home. Two patients were in the 
premanifest phase, 12 patients in manifest phase, three in stage 1, three in stage 2, four 
in stage 3 and two in stage 4. Mean Total Functional Capacity (TFC) was 9.518 (Table 3.1).
background of end-of-life wishes
Most patients refer to their experience with the affected parent or other relatives and 
speak about it frequently and spontaneously. For many patients this has resulted in an 




Gender Age Marital status Advance 
directive
Wishes TFC Disease 
stage
1 Female 33 Married No Yes 13 NA
2 Female 37 Married No No 10 2
3 Female 54 Relationship No Yes 1 4
4 Male 43 Married Filling in papers Yes 11 1
5 Male 56 Married Yes Yes 1 4
6 Male 67 Divorced, 
ex-wife care giver
Yes Yes 3 3
7 Female 68 Married No No 5 3
8 Male 44 Married No Yes 11 1
9 Female 28 Single No Yes 4 3
10 Female 45 Relationship No No 12 1
11 Female 35 Relationship No Yes 9 2
12 Female 70 Single No No 6 3
13 Male 44 Married No No 12 NA
14 Male 66 Married Yes Yes 10 2
TFC = Total Functional Capacity, NA = Not applicable.
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table 3.2 Background and presence of end-of-life wishes in HD patients and conversations with 
their physician about the wishes
1 R11: “When I saw my mother in the end stage of HD, I thought, if I have to go through this one day, 
will I be able to cope.” 
2 R9: “Not the way my mother suffered.”
3 I: “Do you ever think about the future?” R4: “Of course, every day. “ I: “what do you think? Are there 
things you would want?” R4: “I am not going to leave home. I have seen that with my mother. As 
soon as I become dependent on others, then it is time to pull the plug. When I am not able to eat 
independently or be independent, that is unacceptable. If my quality of life diminishes to a point 
that I become dependent, than I quit.”
4 I: “Do you have any wishes or ideas for the future?” R9: “Well yes. That you tell others that you 
don`t want to go on. That you tell about what is acceptable and what is not, you know. Say, if you 
can`t go to the toilet anymore.” I: “Did you ever think about what would be acceptable for you and 
what not?” R9: “Well, if I have to move to a nursing home, that seems awful. Because I can`t take my 
cats with me.”
5 I: “And if I ask about that, about the end of life. Is that something to discuss?” R1: “Yes, we can 
discuss that.” I: “What does it mean for you?” R1: “If I have to be fed, then, I think, I will have had it.”
6 R1: “We wondered sometimes if it is at all possible. We didn’t know if it might be possible to make 
arrangements now or in fact whether it is possible to make arrangements at all.”
7 I: “You said to me that when things become worse, that would not be preferable. You talked about 
suicide. Did you ever think about euthanasia?”R8: “Yes, euthanasia, yes, but to come to that point, 
things have to be a lot worse, my situation would have to get worse. If I look at my dad, he seems 
content with the situation. But with me, things can be totally different.”
8 R11: “Every day I keep hoping that the solution in Canada, with mice, where the disease has been 
halted. I have hopes that maybe a time will come for me, when I am not that ill, that I have to start 
thinking about euthanasia; that a solution will be found in some other area.”
9 R3: “I had a conversation once with the NHP. About the future…I am glad you came. Because now I 
have told you what my wishes are.”
10 R2: “I do not want to make a decision about the future now. There are so many options nowadays. 
We will see.” 
11 R7: “I usually keep it simple. It is easy said, but I am not going to make a fuss. What will be, will be.” 
12 R13: “I do not see a long-term future for myself. I do not think I’ll have much of a say.”
13 R5: “I started thinking about euthanasia about 10 years ago. I saw another patient with HD who 
didn`t know anything and I thought that is not what I want. And I filled in an advance euthanasia 
directive. And now I am further down than I, eh, I said I did not want to move to a nursing home, but 
now here I am, I moved here a month and a half ago. Things were not going well at home. Then we 
talked about it, saying if it is like this, end it. And then things change, my wishes changed. And we 
got a granddaughter. So now I am in a nursing home.”   
14 R1: “Of course you can’t say now how you will think in 10-15-30 years’ time.”
end-of-life wishes (Table 3.2, Quotations 1 and 2). End-of-life wishes usually consist of 
thoughts concerning euthanasia or PAS in the course of the disease. Euthanasia, end-of-
life wishes and the threshold of what an acceptable life or what quality of life entails are 
concepts that are intertwined when thinking and talking about this subject.
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Presence of wishes
From the interviews, three patterns emerged regarding the presence of wishes. One 
pattern is recognised in a group of patients that has an advance directive or was making 
one at the time of the interview (4 respondents). The advance directive was usually a 
euthanasia directive and respondents talked about euthanasia and what their threshold 
of acceptable life would be (Table 3.2, Quotation 3).
The second pattern revealed patients who have some general ideas about their future 
perspective and mostly circumstances or events they wanted to avoid, but had not yet 
specifically articulated their intentions (5 respondents). They found it difficult to put their 
thoughts or wishes into words (Table 3.2, Quotations 4 and 5). Some of them wondered 
if it was possible already to document wishes or was it better to postpone (Table 3.2, 
Quotations 6 and 7). And sometimes a patient wanted to keep up hope and wait for 
a solution (Table 3.2, Quotation 8). The respondents in this group indicated that they 
would like to have their intentions known and/or documented, for the future (Table 3.2, 
Quotation 9). 
The third group (5 respondents) has no (distinct) end-of-life wishes or questions regarding 
this subject, although the reasons behind this differ. Three patients take life as it comes. 
One of them had never really thought about the possibility of having a wish about the 
end of life (Table 3.2, Quotations 10-12). One patient had thoughts about death and being 
a burden to others, but these thoughts did not result in an end-of-life wish.  
Response shift (adapting to the disease or deviating from anticipatory beliefs) is an issue 
of concern for all patients, those with no wishes, those with general ideas about their 
wishes and for patients with more specific wishes and advance directives. Some patients 
decided not to draw up an advance directive because of potential response shift (Table 
3.2, Quotation 13-14).
Knowledge about euthanasia, advance directives and other end-of-life wishes
The majority of respondents have thoughts about the end of life and are aware of the 
concept of euthanasia. Most of them, however, do not know how to have their wishes 
respected and/or carried out. They were not able to say exactly what was required nor 
did they know what the concept of euthanasia or PAS really means, in terms of the law or 
in terms of requirements (Table 3.3, Quotation 1). On the other hand some already have 
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a fair grasp of the relevant underlying values of the requirements, without being able 
to make these explicit (Table 3.3, Quotations 2 and 3). Several patients thought that it is 
necessary to be able to talk about your wishes and ask for them to be carried out (Table 
3.3, Quotation 4).
role of family and physician
Family, partners and friends proved to be important for many patients. Their thoughts 
and wishes were usually discussed with these persons first, or patients indicated that 
they would want to talk to family and partner first (Table 3.4, Quotation 1). These 
discussions can be brief and not always directed towards the specific goal or intention of 
clarifying and discussing their wishes. The role of family members was sometimes even 
more important than the cooperation and role of their physician, usually the general 
practitioner (GP) (Table 3.4, Quotation 2). In fact not all patients had discussed their 
wishes with their physician in some cases ascribing this to the nature of their relationship 
with their physician, usually their GP. One patient discussed his wishes when he drafted 
an advance directive but not afterwards (Table 3.4, Quotations 3, 4 and 5). The patients 
who did talk about end-of-life wishes talked to their GP or nursing home physician (NHP). 
table 3.3 Knowledge about euthanasia, advance directives and other end-of-life wishes 
1 I: “Can you tell me something about euthanasia?” R9: “That you write down your limit, so to say, 
what is acceptable and what is not, for example when you`re not able to shower anymore or when 
you need help to eat. And that you can end your life, when you reach that point.”
2 I: “we talked about euthanasia earlier, can you tell me what you know about euthanasia?” R8: 
“Euthanasia, You have to put it in writing in a euthanasia directive, that’s what you want. I think you 
have to talk to a doctor. It is not something that just passes. And it has to be a serious situation. That 
you suffer unbearably. But, that is different for everyone. That`s it.” I: “you said suffer unbearably, 
what would that behold?” R8: “Yes, it has to be that you do not see a way out for yourself. That you 
are in a certain situation that you are totally grasped by the disease and that things are very rough, 
to stay alive. To put it like this, yes.”
3 I: “you mentioned an advance euthanasia directive. Can you tell me how you became known with 
it?” R11: “Yes. I am not sure if I will be strong enough at that moment. I have always been strong, 
but maybe in the future I think that my life is not worth living anymore. Sometimes I think it is 
important to draw it up (advance directive), and sometimes I think, because you have to be totally 
‘with-it’ before you sign, right? Yes, you have to be able to say that you can no longer cope with the 
situation and that these are the things you can no longer take.”
4 R1: “Often you are no longer allowed to make your own decision. When someone is too ill, it is not 
allowed anymore, someone else has to decide then.” 
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dIscussIOn
In The Netherlands, end-of-life wishes, especially euthanasia and PAS, are frequently 
discussed subjects. In a non-selected group of 19 HD patients who visited our clinic, 
more than half were willing to talk or had already talked about their disease perspective, 
including end-of-life wishes. Most of the wishes concern euthanasia or PAS, because 
of wanting a situation arising, and wanting to stay in control. But knowledge about the 
requirements concerning advance directives, euthanasia or PAS is sometimes limited and 
wishes remain vague. 
Wishes
Earlier research showed that many patients in a nursing home (mean age >80 years) have 
end-of-life wishes; these may not always involve euthanasia or PAS.19 For many people, 
thoughts or wishes for the end of life consist of a general idea of what they want or want 
to avoid; in retrospect it is sometimes uncertain whether a person foresaw this particular 
situation, when making the advance directive.20 HD patients, usually much younger, know 
that their future will be characterized by deterioration and loss of control. Wishes are 
present, sometimes distinct, sometimes a vague indication of what they would and would 
not want. Some patients see their future as being too insecure to have wishes. And by 
expressing wishes or talking to your physician, the subject and the consequences become 
real; it can imply giving up hope as a patient.21;22 
table 3.4 Role of family and physician 
1 R6: “Yes, we are pro-euthanasia. I am preparing, together with my wife. The lawyer came and asked 
about an advance directive. And then we’ve gone back to our GP and we have the NVVE papers 
(Right to die-NL).”
2 R4: “My wife and friends have to give their consent. They have to make sure that my wishes are 
carried out if I can’t see to it myself anymore.”
3 I: “did you talk to your GP about your wishes?” R4: “No, not yet. Yes, he knows, I have the same GP 
as my mother had, so he knows about what should be done. But otherwise, I have no relationship 
with my GP. If I have any questions I visit the professor. And my GP, he doesn`t really know about the 
disease.”
4 R7: “My GP, no I never visit him. No, he is nice, but he is of no help.”
5 R5: “Yes, I talked about it with my GP and he gave me a leaflet about euthanasia. Then I handed in 
the advance directive. I do not remember what we talked about after that.”
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In this study most patients frequently spoke about the adverse experience with an 
affected parent, which determined their wishes about end of life, sometimes leading to a 
wish for euthanasia. Their answers reflected a wish to stay in control of their own life and 
death; this would seem to be in accordance with the wish of patients with other diseases, 
such as cancer or ALS, but the background to these thoughts differs.12 
Knowledge about advance directives and the role of family and physician
Although we discovered that many patients in this study have end-of-life wishes, not 
all of them discussed these with their physician. Earlier research studies have reported 
that patients usually fill in their advance directive papers and discuss them briefly with 
their physician at the time, but not later.6 Little is known about the reason for the lack of 
discussion; we can draw several conclusions from our study. 
Discussing end-of-life wishes requires a good and trusting relationship between patient 
and physician. Most patients referred to their GP when talking about end-of-life wishes, 
some to their NHP. Some patients hardly ever see their GP and do not take the initiative 
to discuss their wishes and thoughts, sometimes because the patient assumes his/her 
GP knows little about the disease. Moreover, patients lack knowledge about the value of 
an advance directive, the physician’s role and how to get to the point where the wishes 
are respected. This was demonstrated by the patient’s perceived importance of family 
in the process of drawing up an advance directive. In law however, the family is not part 
of the process. Family does not have to give their consent or agree with the patient. The 
conversation between patient and physician is the only thing that counts. A recent study 
in The Netherlands amongst Dutch citizens demonstrated an increased awareness about 
the option of euthanasia. It also revealed that citizens do not always use the terms of the 
law the way they are meant. In a vignette study, most citizens knew that family does not 
have to give consent, but agreed that family has an important role in the process.7
Another indication of lack of knowledge is the observation that some HD patients seemed 
to think that things have been taken care of once the advance directive has been composed, 
discussed and filed. A recent case of euthanasia in a patient suffering from HD was deemed 
incorrect because of the very limited conversation of the patient with her physician about 
her wishes and threshold.10 A Dutch study showed that patients have high expectations of 
their advance directive in case of dementia while these expectations are not met by their 
physicians, usually attributable to the lack of a proper conversation about the topic.6;13 
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Some 7% of the Dutch population has an advance directive in case of dementia; the focus 
on and attention paid by society to this subject shows an increasing awareness of the 
options offered by an advance directive, especially with the increase in prevalence of 
neurodegenerative diseases.6;23 But patients in the present study were not always aware 
that they could draw up an advance directive and express their wishes at an early stage of 
the disease.
Interestingly, a few months after the interviews we learned that two patients (Respondents 
10 and 12) had in the meantime created an advance directive, drawn up together with 
their nursing home physician. It should be noted that we posed open questions and did 
not provide any information concerning Dutch euthanasia law. This shows that end-of-life 
issues are important subjects for patients. Patients may want to talk about the subject, but 
do not always know how, when or with whom. Taking this step and making arrangements 
for their own future gave both patients peace of mind, indicating the (apparent) 
importance of a physician asking actively about end-of-life wishes in all patients.24;25
Response shift, competence and the role of advance directives
An important issue in the applicability of advance directives is response shift, especially 
in the context of a disease where cognitive decline is a key symptom.26-28 Twelve cases of 
euthanasia in patients in early stages of dementia were reported in The Netherlands in 
2009.10 From a judicial point of view, it can be argued that the subject of response shift 
does not apply to patients with dementia because when patients become incompetent 
there is no longer any will, only their previous wishes remain judicially valid. Thus, it only 
matters if the physician knew his patient prior to the dementia. But this would entail 
totally disregarding the current situation, and the fact that patients sometimes do have an 
opinion about their present life. Promoting patient autonomy by applying a previous wish 
into an actual wish means ignoring the time between the writing and current events.29;30 
GPs report they regard consistency of the will and physician-patient relationship as 
most important factors when deciding if response shift is an issue. NHP regard advance 
directives as a useful tool, but not a document on the basis of which they would make 
decisions.31 This supports the views from literature that it can be difficult to decide if an 
advance directive applies,4;32;33 but ignores the finding that early stage dementia patients 
are able to describe their situation27;29;34 or the fact that most HD patients have had a 
glimpse of their future, through a family member.
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We explored the existence of end-of-life wishes in HD patients. Our questions were broad 
and directed towards thoughts about and wishes for the end of life in general and not 
immediately directed towards euthanasia. Most of the respondents talked about their 
wishes in the context of their threshold of acceptable life and euthanasia. This shows how 
much euthanasia and end-of-life wishes are intertwined in The Netherlands and that they 
are at the forefront of many patients’ minds. 
We reached saturation but to substantiate our findings a quantitative study must be 
undertaken. One limitation is that we interviewed only two patients in the premanifest 
phase, although these did not reveal any difference in themes. Furthermore our group of 
patients represented all stages of the disease and ranged from before onset until being 
almost totally dependent, thus showing that disease stage did not alter the relevant 
themes. 
A second possible limitation is the potential existence of cognitive deterioration in our 
group. Patients were not explicitly tested beforehand. But especially in a disease where 
cognitive deterioration is a key symptom, we think it is important to ask these patients 
in particular for their opinion and ask about their wishes. The study showed that most 
patients are still able to speak about their lives and their wishes and that it was possible 
to extract these. Thirdly, the interviews were carried out by the first author of this article, 
who also is a physician. This fact was known to the patients. Bias is possible because of 
the role of the researcher, especially with a subject where the physician is the central 
figure in Dutch law. But the author was not the treating physician and we emphasized 
that the opinions would be dealt with confidentially and not provided to a GP or other 
treating physicians.    
To the best of our knowledge, this is the first study in which patients were actively asked 
for their thoughts and attitudes towards the end of life and the content of wishes for the 
end of life, without prior selection. The study demonstrated that asking patients these 
questions is not problematic. 
Patients with HD think about their future perspectives and how to stay in control of both 
their life and their death. The example of a parent is the strongest motive for having end-
of-life wishes and determining a threshold of acceptable life. Probably more patients have 
wishes than those known to their physician, but have not communicated these with their 
physician for several reasons, including a lack of knowledge. Both the finding that patients 
were not always aware of the fact that it is possible to draw up an advance directive at 
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an early stage of the disease and the finding that only a minority of individuals with early 
dementia are able to complete an advance directive points out the important conclusions 
of an earlier study on advance directives in HD that it is important to talk about this 
subject early on in the disease.35;36 
If such a conversation is initiated by the physician, response shift can be detected at an 
early stage, possibly preventing anxiety because of future incompetence. For patients, 
more information about the (im)possibilities of an advance directive can help them put 
their wishes into words so that these are carried out in good time. Future research is 
needed to study if the presence of wishes and the content of these wishes is associated 
with certain patient characteristics, such as age, gender, religion or disease stage. 
Not only for patients in the Netherlands, but also for patients in other countries where 
advance treatment directives are valid, possibly not for euthanasia, but for other medical 
decisions , these conclusions may help physicians to engage in conversation, provide 
information, increase knowledge and inform a patient in good time about their options 
and about how to ensure their wishes are respected. And to extend this suggestion 
even further, these conclusions could also help physicians in countries where advance 
directives do not have a status to realize the possibility that thoughts and wishes for the 
end of life might be present. Furthermore these conclusions can be applied not only to 
HD, but also more widely to other neurodegenerative diseases.
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Objective: To investigate the presence of thoughts or wishes for the end of life 
in patients with Huntington’s Disease (HD) or identified gene carriers (further 
mentioned together as patients). 
Methods: A custom-made questionnaire, based on previous qualitative research, was 
sent out to 242 patients with HD and identified gene carriers. Presence of wishes was 
investigated and correlated to demographic and clinical characteristics.
results: A total of 134 patients (55%) returned the questionnaire. One-hundred-
and-one respondents (75%) reported to have some kind of thoughts or wishes 
for the end of life. For fifteen respondents (11%) these thoughts concerned care; 
eighty-six respondents (64%) reported to have also thoughts about euthanasia or 
physician assisted suicide (PAS). The presence of any thoughts about the end of life 
was significantly related to being familiar with HD in the family, but not related to any 
other demographic or clinical variable. Participants with thoughts specifically about 
euthanasia or PAS were of higher education and in earlier stages of the disease than 
participants without such thoughts.  
conclusions: Thoughts or wishes for the end of life are present amongst patients 
with HD. These thoughts include euthanasia or PAS in a majority of the respondents. 
It is suggested that prudential addressing these issues may enhance the doctor-
patient relationship.
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IntrOductIOn
Euthanasia and physician assisted suicide (PAS) are legal in The Netherlands since the 
law of 2002 passed, but under strict conditions.1 Euthanasia is defined as death brought 
upon by a physician at the patient’s explicit request, either voiced orally or based upon 
a written advance directive.2 Approximately 2% of all annual deaths in The Netherlands 
result from euthanasia or PAS.3 In The Netherlands we recognize several kinds of advance 
directives. We recognize advance treatment directives, for example “Do not resuscitate” 
which a physician must abide to. A request for euthanasia or PAS, documented in a 
written advance directive is not a right of a patient but a request, without binding legal 
consequences.4 Physicians generally do not initiate a conversation about end-of-life 
wishes and have difficulty handling an advance directive even though situations for which 
the advance directive was intended were recognized.5-8
Huntington’s Disease (HD) is an inherited neurodegenerative disease, characterized 
by movement disorders such as chorea and hypokinesia, by cognitive decline leading 
to dementia, and by psychiatric symptoms. The localizing gene was identified in 1993 
and this discovery made genetic testing possible.9 In the Netherlands the prevalence is 
approximately 1,700 patients and another 6,000-8,000 people are at risk.10 Between 50 
and 60 patients suffering from HD die each year.11 Since 2005 6-10 HD patients died every 
year after euthanasia or PAS.12
Qualitative research, by means of in-depth semi-structured interviews with physicians 
familiar with HD and HD patients preceded this study.13;14 From these studies we 
concluded that most physicians leave it up to the patient to initiate a conversation 
about their wishes for the end of life. Furthermore we learned that some patients have 
specifically articulated their intentions, usually to family members. Other patients already 
had some ideas or wishes for the future, but did not know if it was possible to document 
these already or hesitated to discuss these, because their thoughts and wishes were not 
clear to them yet. We also found that patients underestimated the important role of their 
physician in the process of documenting wishes for the end of life and in the process of 
having these wishes fulfilled. 
For the purpose of the present study we developed a questionnaire to explore the 
presence of end-of-life wishes, the reasons for having these wishes, the presence of 
advance directives and the conversations about end-of-life wishes in a larger group 
of HD patients or identified gene carriers (further mentioned together as patients) in 
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the Netherlands. The first aim of this study was to explore whether there is any way to 
predict which patients are most likely to benefit from discussion of end of life issues. We 
wanted to explore if end-of-life wishes are present in the Dutch HD population, what 
the wishes include and if the presence of wishes is related to demographic or disease 
specific characteristics, such as cognition, quality of life and severity of motor symptoms. 
To investigate if wishes are related to any characteristics, we distinguish two groups, a 
group of respondents with wishes and a group without any wishes. Furthermore, we 
make a (second) distinction between respondents considering euthanasia or PAS and 
respondents with other types of wishes. The second aim was to investigate if HD patients 
or identified gene carriers use advance directives and if they talk to family or a physician 
about their wishes. 
MEtHOds
Study population
The study was a single center study in the Leiden University Medical Center, which is 
a national referral center for Huntington’s Disease. Patients visiting our out-patient 
clinics are requested to register in the International HD Registry. Those who consented 
to be included in the registry could also consent to being approached for participation 
in scientific studies. For this study we screened 296 patients that were included in the 
registry database since the database was set up. We screened between September and 
December 2011. Inclusion criteria were: a genetically proven status of HD gene carrier, 
age above 18, able to communicate either oral or in writing. Exclusion criteria were: no 
informed consent, suffering from severe depression according to the medical record, 
absence of a medical record, addiction to alcohol or drugs or having suicidal ideations at 
present. Fifty-five patients were excluded because they declined informed consent to be 
approached for scientific research, had severe depression or suicidal ideations or because 
their last visit was too long ago (>3 years) and we missed accurate information about 
their present condition. 
In addition 5 patients were included via the Dutch Huntington’s Disease patients’ 
association after posting an announcement in their quarterly. Two hundred and forty two 
questionnaires were sent out in January 2012. A reminder was sent to non-responders in 
March 2012.
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Instruments and data collection procedure
A custom made questionnaire was developed for this study. The items were based on 
clinical experience, literature, and qualitative research that preceded this study.15;16  
First, information on demographic characteristics was collected. Age was calculated on 
January 2012, when the questionnaire was sent out. Educational level was evaluated 
using a nine-point scale that was subsequently categorized into three categories, lower, 
middle and higher education (according to the categories used in the Registry European 
HD Network questionnaire). Data on the subject’s religion was collected. The importance 
of religion for the patient was dichotomized into not important and important. Familiarity 
with HD was assessed by asking if the respondent was familiar with HD in the family and 
which parent is or was ill. 
Second, to explore any wishes about the end of life, the first question concerned if 
respondents ever thought about the end of life and what the contents of these thoughts 
were. This question provided several options and the respondent could give multiple 
answers. In addition, reasons for having these wishes and conversations about the 
wishes, either with family members or with the general practitioners were assessed. 
Third, several questions assessed the presence of advance directives for end-of-life 
wishes. Items regarding the end of life in HD patients addressed euthanasia or PAS, tube 
feeding, admittance to a nursing home, care at home or treatment for other diseases. We 
categorized the responses to these items into no wishes, wishes except euthanasia or PAS 
and wishes including euthanasia or PAS. 
Quality of life was evaluated using a nine-point numeric scale ranging from 1 (really bad) 
to 9 (excellent) (modified from SF-3617).
In addition to the custom-made questionnaire, global functioning was assessed using 
the Total Functioning Capacity (TFC) subscale of the Unified Huntington’s Diseases Rating 
Scale (UHDRS). The TFC consists of 5 questions assessing employment, the capacity to 
handle financial affairs, manage domestic chores and perform activities of daily living; 
and the care level provided.18 Motor function was assessed using the UHDRS motor 
score (UHDRS-M), ranging from 0-124 points.19 A score below 5 denotes no motor 
abnormalities. Mini-Mental State Examination (MMSE) data were collected to assess 
global cognitive functioning.20 The TFC and UHDRS-M are performed by a neurologist 
and the MMSE is performed by a neuropsychologist, both experienced with HD, at every 
visit to our out-patient clinic as part of the Registry data collection. The TFC, UHDRS and 
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MMSE scores used in the present study were those that were obtained at the time point 
closest to the date the questionnaire was completed (or sent), and had to have been 
collected within the previous 12 months. If the last available test score was more than 
one year earlier, the result was recorded as missing.
Statistical analysis
Data were analyzed with SPSS 20.0. Data are presented as n (%) or mean (SD) as 
appropriate. The Chi-square test (or Fisher’s Exact Test, when appropriate) was used 
to test for group differences with respect to categorical data, whereas t-tests for 
independent samples were used for normally distributed continuous data and Mann-
Whitney U tests for samples with non-normally distributed continuous data. The 
significance level was set at p < 0.05.
rEsults
General respondent information
One-hundred-and-thirty-four out of 242 questionnaires were returned, a response rate of 
55.4%. One respondent returned the questionnaire with negative remarks, indicating that 
this was a subject the respondent did not want to discuss (Figure 4.1). If a respondent 
decided not to answer to a specific question, the result was recorded as missing. 
Respondent and non-responder characteristics are summarized in Table 4.1. The non-
responders that were deceased or moved were not included in the analysis.
Thirty-four respondents have the maximum TFC score of 13. Thirty-one respondents have 
the maximum MMSE score of 30 and 36 respondents have a motor score of 5 or lower. 
Non responders were younger and of lower education than responders, but were not 
different considering gender, having a partner, or disease specific characteristics such as 
TFC and UHDRS-M.
thoughts about the end of life
Thirty respondents indicated to have no thoughts about or wishes concerning the end 
of life. Three respondents did not answer this question. The remaining 101 respondents 
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table 4.1 Characteristics of 134 respondents and 99 non-responders 
Respondents Non-responders p-value
demographics
Female 71 (53%) 63 (64%) 0.06
Age, years (mean, range) 51 (21-85) 47 (20-78) 0.02
Married or partner 100 (74.6%) 63 (61.8%) 0.06
Education 0.001
Lower level 35 (26.1%) 35 (34.0%)
Middle level 52 (38.8%) 51 (49.5%)
Higher level 46 (34.3%) 14 (13.6%)
Religious 43 (32.1%) -
Acquainted with HD in family 101 (75.4%) -
Conversation with family about HD 125 (93.3%) -
clinical characteristics
TFC (mean, SD)                        8.5 (3.9) 8.3 (4.3) 0.72
UHDRS-M (mean, SD)             30.2 (26.1) 28.0 (27.4) 0.57
MMSE (mean)                    26.5
Quality of life (mean, SD)         6.02 (1.8) -
HD = Huntington’s Disease, TFC = Total Functional Capacity, UHDRS = Unified Huntington Disease Rating Scale-
Motor, MMSE = Mini Mental State Examination.
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indicated to have some thoughts about the end of life. Thoughts are for example: “Not 
the way my mother suffered” or “as soon as I become dependent on others, than it is 
time to pull the plug” or “euthanasia, yes, but to come to that point, things have to be a 
lot worse” (for further qualitative statements: see reference 14). 
Having witnessed HD in close relatives was significantly associated with the presence of 
wishes for the end of life. The presence of wishes for the end of life was not associated 
with gender, age, marital status, education, considering oneself as a religious person, TFC, 
UHDRS-M, MMSE or quality of life (Table 4.2).
respondents with thoughts about or wishes for the end of life
Of the respondents who reported to have thought about the end of life, 86 indicated 
that wishes concerned thoughts about euthanasia or PAS together with other wishes 
for example about the possibilities of care. Fifteen respondents indicated that wishes 
concerned only the possibility of care, either at home or in a nursing home and 
possibilities of tube feeding and other medical treatments. The reason most often 
mentioned why thoughts about the end of life emerged was the loss of personal dignity. 
table 4.2 Characteristics of patients with and without thoughts about the end of life 




Male 12 (40%) 49 (48.5%) 0 0.41
Age in years (mean, SD) 47.1 (14.5) 52.3 (13.7) 0 0.08
Married or partner 22 (73.3%) 77 (77.8%) 1 0.68
Education 1 0.08
Lower 9 (30%) 26 (26.0%)
Middle 16 (53.3%) 36 (35.0%)
Higher 5 (16.7%) 38 (38.0%)
Religious 10 (33.3%) 31 (31.0%) 1 0.81
Familiar with HD in family 19 (63.3%) 79 (81.4%) 4 0.04
clinical characteristics
TFC (mean, SD) 7.69 (4.5) 8.69 (3.8) 2 0.37
UHDRS-M (mean, SD) 31.07 (29.0) 29.53 (25.4) 2 0.94
MMSE (mean, SD) 25.58 (4.4) 26.8 (4.2) 12 0.14
QOL (mean, SD) 6.37 (1.7) 5.97 (1.8) 1 0.40
HD = Huntington’s Disease, TFC= Total Functional Capacity, UHDRS-M = Unified Huntington Disease Rating 
Scale-Motor, MMSE = Mini Mental State Examination, QOL = Quality of Life, SD = Standard Deviation.
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Of the respondents who reported to have thought about the end of life 78 (77.2%) 
discussed these wishes with partner or family members. Forty-three (42.6%) respondents 
reported to have discussed their wishes with their general practitioner and 58 (57.4%) 
did not. Reasons for not talking about end of life wishes were not being ready for it in 
26 (45%) of these respondents and the fact that they had little or no contact with their 
general practitioner in 16 (28%) respondents.
respondents considering euthanasia or physician assisted suicide
Eighty-six out of 134 respondents had wishes concerning euthanasia or PAS at some point 
in the disease process (Table 4.3). The respondents with wishes concerning euthanasia or 
PAS were of higher education and had lower motor scores, compared to the patients with 
wishes concerning only care. There was a trend towards higher overall functioning on the 
TFC for respondents who thought about euthanasia or PAS. Furthermore, respondents 
with wishes concerning euthanasia or PAS discussed their wishes more often with both 










Male (n, %) 6 (40%) 43 (50%) 0 0.48
Age in years (mean, SD) 56.1 (11.9) 51.6 (14.0) 0 0.25
Active Religion (n, %) 8 (53.3%) 23 (27.1%) 1 0.07
Married or partner (n, %) 13 (86.7%) 64 (75.3%) 1 0.51
Education 1 0.03
Lower 6 (40%) 20 (23.5%)
Middle 8 (53.3%) 28 (32.9%)
Higher 1 (6.7%) 37 (43.5%)
Conversation with GP (n, %) 1 (6.7%) 42 (48.8%) 0 0.002
Good relationship with GP (n, %) 11 (73.3%) 72 (84.7%) 1 0.28
Familiar with HD in family (n, %) 10 (66.7%) 69 (84.1%) 4 0.15
Conversation with family 7 (46.7%) 71 (82.6%) 0 0.005
clinical characteristics
TFC (mean, SD) 7.1 (3.3) 8.9 (3.8) 1 0.06
UHDRS-M (mean, SD) 41.8 (24.9) 27.4 (25.0) 1 0.03
MMSE (mean, SD) 24.7 (5.3) 27.1 (3.9) 8 0.14
QOL (mean, SD) 5.3 (2.1) 6.1 (1.8) 1 0.19
GP = General Practitioner, TFC= Total Functional Capacity, MMSE = Mini Mental State Examination, UHDRS-M 
= Unified Huntington Disease Rating Scale-Motor, QOL = Quality of Life, SD = Standard Deviation.
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family and their general practitioner than respondents with wishes concerning only 
care. There was a trend towards considering oneself more often as a religious person for 
respondents with wishes concerning only care at the end of life.
Advance directives
Forty-two respondents (31.3%) had an advance directive; in 33 cases this is a euthanasia 
request, together with other kinds of advance directives, for example not to resuscitate 
(DNR) or a treatment prohibition, and in 8 cases this is a euthanasia request only. One 
respondent did not specify what kind of advance directive he/she had. Respondents with 
an advance directive are slightly older than respondents without, 54.6 years versus 49.2 
years of age (p=0.038) and consider themselves more often as non-religious (p=0.029). 
dIscussIOn
This study shows that, when asked, the majority of HD patients visiting our out-patient 
clinic has thoughts about their end-of-life. The presence of wishes was not correlated 
with any demographic variable with the exception of familiarity with the disease in close 
relatives. The majority of HD patients did discuss their thoughts or wishes for the end of 
life with their family members, but less than half discussed these with a physician. The 
majority of the wishes consists of wishes concerning euthanasia or PAS. The presence of 
advance directives is limited. 
This study shows that, at least on the basis of the variables included here, it is not 
possible for a physician to distinguish, in advance, between patients who have wishes and 
patients who do not. For this reason physicians should prudentially discuss wishes for the 
end of life. It is our experience that such attention for intimate issues may enhance and 
deepen the doctor-patient relationship.
Presence of wishes
Seventy-one percent of respondents in a large Dutch study in the general population 
(n=1,980)  about end-of-life wishes indicated that they have thought about medical 
treatment and decision making for the end of life.21 Mean age of the respondents was 
53.7 years. Forty-one percent of respondents indicated that they had discussed this 
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subject with family members, and only 4% with their physician. Respondents in that 
Dutch study were of higher education than in the general population.21 Respondents in 
our study were about the same age. The percentage of respondents that have some kind 
of end of life wishes in our study is consistent with the national survey, indicating that 
in the Netherlands wishes for the end of life are present both in healthy citizens and in 
patients suffering from a neurodegenerative disease. We can conclude that patients with 
HD do not think about the end of life more or less frequent than persons from the general 
population, but that there are specific characteristics in HD patients that lead to these 
thoughts such as being familiar with the disease and motor signs and symptoms. 
A larger percentage of respondents in our study discussed their wishes with either 
family members and/or their physician than in the general population. Most HD-families 
have witnessed the disease course in more than one generation and many of the family 
members face the disease themselves which may have raised ongoing discussions about 
what to do in the last stages of the disease. 
Both respondents in the national survey and in our study were of higher education than 
non-responders. On the other hand, level of education was not correlated with the 
presence of wishes in our study and therefore it is unlikely that this potential source of 
bias influenced our results. 
Advance directives
In the Netherlands 95% of people know about the existence of a law concerning the end 
of life and 75% know what the term euthanasia means and includes.21 Seven percent 
of Dutch inhabitants have an advance directive, usually a euthanasia request in case 
of dementia.21;22 The percentage of patients with an advance directive is higher in our 
study sample than in the general population. This can be explained by the fact that 
we investigated a selected sample of known mutation carriers and HD patients. These 
patients with HD usually witnessed the appalling disease course in one or more close 
relatives. The need for control and have a say in their own future was reported as a 
reason for making an advance directive and considering specific arrangements for the end 
of life.14 Staying in control of one’s life and death and making one’s own medical decisions 
is part of autonomy and is part of a patient’s identity.23;24 The fear of losing autonomy and 
dignity are described as reasons for asking for euthanasia or making other decisions for 
the end of life.25;26 Research in the USA showed that the prevalence of advance directives 
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increases with age or when people become ill. People seem to formulate an advance 
directive when it is likely they will need one.27 Other research showed that discussing 
end-of-life choices by health care workers resulted in a selection of those choices by HD 
patients, relatives or legal representatives in 75% of individuals.28
religion
In our study considering oneself a religious person was not correlated with the absence 
or presence of wishes for the end of life, in contrast to other research where religious 
persons and patients have objections towards euthanasia.29-31 
The Netherlands is a highly secularized country and the debate about euthanasia started 
in the 1960s.4 The number of inhabitants visiting a church has been decreasing since 
1960. Estimates are that around 2020 more than 70% of Dutch inhabitants will not be 
affiliated with any religion.32 However in respondents who have wishes, there was a trend 
among religious patients to think more often about care than about euthanasia or PAS. 
The strengths of this study are the relatively large study population of HD patients and 
identified gene carriers and the fact that we applied few exclusion criteria. There are 
some limitations that warrant discussion. First, the response rate was 55%. Analysis of 
non-responder characteristics showed that non responders are younger and of lower 
education, but their disease characteristics do not differ, thus indicating that age could 
be relevant but disease stage, gender and marital status are not; however, given that 
age was only marginally related to the presence of wishes, this seems unlikely. We can 
only speculate about the reasons for not filling in the questionnaire. It cannot be ruled 
out that particularly those patients who do not want to discuss end of life circumstances 
decided not to return their questionnaire, which may then have led to some 
overestimation. Additionally respondents of lower education may be less aware that they 
can already express their wishes without explanation from their physician first. Together 
this may have resulted in some selection bias and the study may thus not be regarded 
as representative for the Dutch HD patients. However, it may also be that non-response 
is not selective, given that the characteristics of non-responders in our population are 
similar to those in the general population, i.e. that they are also younger and less well 
educated. Unfortunately we have no information on the reasons for non-participation.
Second, the majority of respondents still live at home. The group of respondents that 
live in a nursing home and are in the latter stages of the disease is relatively small. Most 
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patients who have been diagnosed with HD are still able to visit our out-patient clinic. 
Bias can occur because the wishes of relatively healthy respondents are included in 
this study and we have limited information of the wishes of more severely affected HD 
patients. On the other hand, consistent with studies in the USA, it is plausible that when 
patients become more severely affected and in possible need of an advance directive, and 
when patients and relatives are educated about the choices, the number of patients who 
think about the end of life and make choices, increases.   
To our knowledge this is the first large study among HD patients to investigate end-of-
life wishes and the first study where a relatively unselected large cohort of patients 
diagnosed with a neurodegenerative disease or knowing that the disease will develop in 
the future was directly asked about their advanced care planning and wishes surrounding 
the end of life. We conclude that many HD patients have end-of-life wishes and that we 
were not able to identify a certain group of patients to whom these questions should be 
specifically directed. Although HD is a neurodegenerative disease with cognitive decline, 
it is evident that many patients think about their future, the end of life and about ways 
to have a say in the end of life. Furthermore, because HD and other neurodegenerative 
diseases are relentless and result in difficulties with decision making in due course, we 
advise to discuss end-of-life wishes early in the disease and recommend that physicians 
initiate these conversations with every patient. The fact that less advanced patients, 
with higher education level more frequently refer to euthanasia or PAS shows that it is 
important to talk about these wishes from the earliest stages of HD but also of other 
neurodegenerative diseases when cognition is still intact and decisions can be made, 
based on the fact that as disease advances patients progressively loose insight. The 
finding that less than half discussed their wishes with a physician but many with family 
members shows that physicians should raise the awareness that the topic is of interest 
and of importance to the physician.
We recommend that these conversations should not only be held with patients in The 
Netherlands, where euthanasia and PAS are legal, but also in every other country, 
because we feel that nearly all patients, irrespective of the country where they reside, will 
have thoughts or wishes about the end of life. We expect that also patients in countries 
where euthanasia and PAS are illegal or under debate think about staying in control of 
their life and want to retain quality of life. For this reason we suggest physicians should 
ask every patient with HD or any other neurodegenerative disease early in their disease 
course about their fears, their wishes and thoughts for the future. When talking about 
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euthanasia or PAS is not an option, a physician may discuss for example the desirability 
of tube feeding, or the use of antibiotics in the later stages of their disease. In the 
Netherlands physicians are designated to make medical decisions about starting or 
withholding treatment and following treatment directives and non-treatment directives, 
therefore physicians should hold these conversations. Law and practice in other countries 
determines which health care professional is the designated person to initiate these 
conversations. 
Furthermore we suggest that wishes for the end of life other than euthanasia or PAS 
should be studied in patients with HD in order to examine which questions to ask patients 
in the early stages of the disease. We suggest that these studies should be carried out 
using qualitative techniques at first. 
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Euthanasia and physician-assisted suicide (PAS) by request and/or based on 
an advance directive are legal in The Netherlands under strict conditions, thus 
providing options to stay in control and choose ones end-of-life for patients with 
Huntington’s disease (HD) and other neurodegenerative diseases. HD is an inherited 
progressive disease characterised by chorea and hypokinesia, psychiatric symptoms 
and dementia. From a qualitative study based on interviews with 15 physicians 
experienced in treating HD, several ethical issues emerged. Consideration of these 
aspects leads to a discussion about the professional role of a physician in relation 
to the personal autonomy of a patient. Such a discussion can raise awareness that 
talking about end-of-life wishes with an HD patient is part of the legal, professional 
and moral responsibility of the physician, and that a letter of intent on behalf of 
the physician can improve active participation in the process. Discussion of these 
issues can help to advance the debate on euthanasia and PAS in HD and other 
neurodegenerative diseases.
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IntroductIon
In The Netherlands the euthanasia act was approved by parliament in 2002. Euthanasia 
and physician-assisted suicide (PAS) are considered to be legitimate provided strict 
conditions are met. Approximately 7% of Dutch inhabitants have an advance directive, 
usually consisting of a euthanasia request, mainly as a precautionary measure in 
anticipation of possible dementia.1 Euthanasia is legitimate based on an advance 
directive, but it is seldom performed, because of response shift or loss of competence 
and because physicians hesitate to perform euthanasia based solely on an advance 
directive.1-4 Response shift means adapting to the disease or deviating from anticipatory 
beliefs.
Huntington’s disease (HD) is an inherited autosomal dominant progressive 
neurodegenerative disease, characterised by chorea and hypokinesia, psychiatric 
symptoms and progressive dementia. Age of onset is usually between 30 and 50 years of 
age.5 Despite symptomatic treatment, no cure is available and all patients will eventually 
become totally dependent for all daily life activities. There are approximately 1,700 HD 
patients in The Netherlands and about 5,000-8,000 persons are at risk. Between six and 
ten euthanasia requests in cases of HD have been granted in The Netherlands each year 
for the past five years.6 
As HD is inherited, there is no doubt about the diagnosis after genetic testing and the 
course of the disease is usually known to patients and their families, HD can be used as 
an example for thinking about end-of-life questions in a disease where cognitive decline 
is a key symptom and the ethical dilemmas surrounding this subject. By exploring these 
questions with patients, especially in the premanifest phase, solutions can probably 
be implemented and may also enhance treatment and guidance in patients with other 
neurodegenerative diseases. Besides clinical experience we are not aware of studies on 
euthanasia or PAS or other end-of-life questions in patients with HD. 
The aim of this study is to explore the role of the physician when it comes to talking about 
end-of-life wishes and the value of an advance directive, including its content. From the 
results we propose a new strategy for the treatment and guidance of patients and for 
dealing with end-of-life wishes in patients with other neurodegenerative diseases. 




Between January 2011 and May 2011 a semi-structured interview with fifteen physicians 
was conducted. The physicians were recruited because of their experience with HD and 
their different fields of expertise. Our sample consisted of four general practitioners, two 
psychiatrists, two neurologists and seven nursing home physicians (NHP). Respondents 
were interviewed based on the method of purposive sampling, a commonly used form of 
non-probability sampling. Sample size relies on the concept of “saturation” or the point at 
which no new thematic content is observed in the data. Thematic saturation was reached 
after approximately twelve interviews. Although based on a topic list, the items covered 
by the interview could be expanded on during the interview phase, if new information or 
new insights emerged.7 Interview topics included the communication about euthanasia/
PAS with patients, experience with and moral considerations about euthanasia or PAS in HD, 
experience with advance directives in HD, management of symptoms of HD, in particular 
cognitive decline and psychiatric symptoms. We also addressed the participants’ perception 
of the reasons why patients want to talk about this subject with their physician and possible 
limitations to executing an advance directive. The questions were directed towards cases 
of HD, but sometimes other experiences were also mentioned and discussed. All interviews 
were recorded and fully transcribed. As our study was explorative, we used open coding. 
The transcripts were read and categorised into similar subject areas using inductive coding.7 
Representative quotations were chosen to demonstrate the themes identified.
rEsults
All physicians have more than 5 years experience in their field of expertise. Two GPs 
had a HD patient in their practice and performed euthanasia and two have a HD patient 
with whom they discuss their advance directive regularly. The nursing home physicians 
all work or worked in specialized HD units of a nursing home, except one. Three nursing 
home physicians performed euthanasia or PAS in HD. The psychiatrists and neurologists 
are specialized in HD (Table 5.1).
Conversations about end-of-life wishes
Most respondents feel that talking about end-of-life wishes can bring peace of mind to a 
patient and that having the conversation sometimes makes the subject less pressing. 
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Respondent (R)13: “If subjects are not talked about, they become bigger. So I believe that 
if you discuss it regularly it can prevent euthanasia, or to put it differently, it can have the 
result that patients decide they no longer want euthanasia; it is no longer necessary.” R 4: 
“A more peaceful state of mind can be achieved when a patient talks about euthanasia. 
Peace in the knowledge that they will get help when needed. If counselling and support 
are provided in most cases you will not reach the point of really considering euthanasia.”
Some respondents indicated some hesitation to start the conversation. R 13: “I talk about 
the subject when a patient starts the conversation. I do not enter into the conversation 
spontaneously. Not because I think it is difficult, but because I leave it up to the patient to 
express themselves about this subject.” R 15: “I do not consider talking about euthanasia 
to be part of my job. Unless the conversation is initiated by the patient.” R 14: “I never ask 
about this myself. Because I feel that a patient should start the conversation. I thought 
about this for a long time, but I feel that if a patient is afraid to talk about the subject of 
euthanasia, then the patient is not ready for it.”
On the other hand, respondents remarked that euthanasia and/or PAS is an option a 
patient should know about. R 2: “I told my patient, I’m open to talk about the subject 
Table 5.1 Characteristics of physicians 
Respondent
(R)/ Type of 
physician
Number of 




in euthanasia in HD 
Raises the issue 
of advance 
directives
Raises the issue 
of euthanasia 
with patients
1, GP 1 Yes/yes Yes Yes 
2, GP 1 Yes/ yes Yes Yes 




4, GP 1 Yes/ yes Yes Reacts
5, NHP >50 Yes/ yes Yes yes
6, NHP >10 Yes/ yes Yes yes
7, NHP >50 Yes/ yes Yes yes
8, NHP >25 Yes/ no Yes Reacts 
9, NHP >70 Yes/ yes Yes yes
10, NHP >100 Yes/ yes Yes Yes 
11, NHP >30 Yes/ yes No, reacts No, reacts
12, psychiatrist >50 Yes/ no Reacts Reacts
13, psychiatrist >50 Yes/yes No, reacts Reacts 
14, neurologist 1 Yes/ yes No, reacts No, reacts 
15, neurologist > 30 Yes/no No No
HD = Huntington’s Disease, GP = general practitioner, NHP = nursing home physician.
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and to perform euthanasia, but it is a journey we should make together.” R 1: “I promised 
my patient I would help him, although this promise was emotionally difficult for me as a 
physician.” 
Advance directives and the role of the physician
The respondents explore the reasons for thinking about drawing up an advance directive 
with their patients. R 6: “The advantage of this disease is that patients do have some idea 
about what their future will be like. Many of them think about the end of life.”
The physicians usually also explain to the patient what they can expect from their 
physician, especially if the questions concern euthanasia or PAS. The physicians explain 
that drawing up an advance directive is letting the physician know what your wishes 
and values are, but it is not a guarantee that the result wished for by the patient will 
be reached. R 4:“He trusts us that we will help him in due course. Although I always tell 
all my patients that euthanasia is not a right.” General practitioners usually discuss the 
advance directive frequently when the wish becomes current or pressing and when it is 
brought up by the patient. Otherwise the advance directive becomes part of the patients’ 
file. 
When the interviewer mentioned that euthanasia or PAS is possible based on a request 
by advance directive, several physicians responded that an advance directive was a useful 
and helpful document in determining the will of the patient, but not a document on 
which they would act. R 6: “It is the actual wish that counts. If this wish no longer exists, 
the advance directive also becomes invalid.” R 10: “I respond to the will expressed during 
conversation. But I have to say, if someone has taken the effort to draw up an advance 
directive, it means something. But the actual will is more important.” 
dIscussIon
In The Netherlands, patients are allowed to make choices regarding end-of-life wishes 
and to express these to their physician. Physicians in this study recognise the fact that 
HD patients think about the end of life and have end-of-life wishes, but do not initiate a 
conversation about this subject. And although advance directives are used, physicians do 
not act solely on the basis of an advance directive. 
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We find there are three reasons why a physician should have a duty to explicitly discuss 
end-of-life wishes with patients diagnosed with HD. 
1. From a legal point of view a physician is bound to inform the patient about his 
prospects with regard to the disease and treatment options (Civil Code art 7:448, 
paragraph 2). In this part of the Civil Code, parliament defined patient rights. 
Parliament also decided to place the physician at the centre of medical treatment. 
During the development of the euthanasia act however, parliament decided that 
euthanasia should be excluded from normal medical treatment. Parliament chose the 
position of the physician and his conflict of duties with respect to euthanasia (respect 
for human life versus the wish of a suffering patient) as the central issue and not the 
patient and his personal autonomy.8 This choice by parliament also means that a 
physician is not obliged to talk about end-of-life wishes and try to find a way to help 
his patient with such a wish. A patient cannot claim or expect euthanasia from his 
physician; it is a request, without legal binding consequences.8 But we argue that the 
legal obligation to inform the patient about his prospects can include the obligation to 
inform the patient about his prospects and options at the end of life.  
2. From a professional point of view, Dutch guidelines state that a physician should act 
in the best interests of the patient, although sometimes the clinician’s integrity can 
be in conflict with patient autonomy.9;10 The Royal Dutch Medical Association (KNMG) 
wrote a paper on the professional role of the physician, advising physicians to initiate 
the conversation about end-of-life wishes at an early stage.11 The KNMG stated that a 
physician should consider talking about this as part of his professional responsibility. 
From the present study one can conclude that the respondents are aware of the fact 
that it is important to talk about the patient’s wishes, but that actually initiating the 
conversation remains difficult, despite KNMG guidelines.  
3. We argue that it is not only a legal and professional responsibility but there is also a 
(moral) obligation to talk about end-of-life wishes.
HD patients ask questions about their prospects (including the end of life). They receive 
a professional response from their physician. Within a physician-patient relationship 
professionalism will be partly fed by moral considerations. And moral considerations will 
become dominant outwith the professional domain. In a physician-patient relationship a 
physician also is a fellow human being and not just a professional. Helping your patient 
and having a relationship, especially in the context of HD, means it is a matter of course 
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to face the end of life. Informing the patient about his prospects can be extended to 
informing about the options at the end of life. Especially when respondents recognise 
that talking about end-of-life wishes can improve quality of life and that euthanasia or 
PAS are options a patient should be aware of. In our opinion talking about quality of life 
and retaining that quality until the end of life leads to talking about quality of dying. If 
the physician does not consider talking about end-of-life wishes or euthanasia as part of 
his job, he may have quite a strict opinion about a physician’s professional task without 
taking moral considerations into consideration. 
If a physician is unable to reconcile euthanasia with his conscience, a referral to another 
physician could be a way of taking the professional and moral responsibility and acting 
in the best interest of the patient. In a society where information concerning euthanasia 
is widely available we suggest that a physician, although not bound to reach the desired 
point but advised to refer when necessary, should consider it his job to talk about options 
at the end of life. Nevertheless, it is clear that a patient with such a request sometimes 
has difficulty finding a physician.3;8;12;13 Thus even when the law only affirms the 
physician’s obligation to inform about the prospects of the disease, and recognises the 
conflict of duties, we argue that a physician could have a moral obligation to re-evaluate 
his opinion about euthanasia or PAS and his response to patients asking for it.
Although legal and professional guidelines and regulations limit the role of other health 
care professionals in this area they can be very important for a patient. Caregivers, such 
as nurses, may be in closer contact with the patient than the physician. The team can fulfil 
an important role in signalling and interpreting the wishes of the patient and sometimes 
a team member is the first person to whom a patient expresses his wishes. Also other 
health care professionals may be the first to signal and communicate this to the physician.
Advance directives
The conversation between patient and physician about end-of-life wishes can result in 
an advance directive. Especially in neurodegenerative disease such as HD, it is advisable 
to describe, determine and record the wishes, and the KNMG in fact advises physicians 
to enter into a conversation when a patient produces an advance directive and not just 
file the document.11 The wishes can be documented by the patient himself or by the 
physician after a conversation and should be attached to the medical record. From the 
response concerning the applicability of advance directives it is possible to suggest that 
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some physicians seem to lack knowledge, especially regarding the applicability of advance 
directives and euthanasia in dementia. Some physicians see the advance directive only as 
a helpful document, as also reported in earlier research.1;3;12 Although the law provides 
a possibility to act, based solely on an advance directive, several reasons have been 
identified in literature why physicians seldom do. Reasons are for example a difficulty 
determining the unbearableness of the suffering and the absence of a (present) wish of 
the person involved. We add a possible lack of knowledge to these reasons. Not only a 
lack of knowledge on the possibility provided for in the law, but on how to fulfil the six 
requirements of the law on euthanasia and replace the request by an advance directive, 
and how to handle cognitive decline, response shift and psychiatric symptoms. 
Letter of intent on behalf of the physician
In order to enhance involvement and awareness of the possibilities provided for within 
the law, we propose a letter of intent on behalf of the physician. A suggestion to or 
obligation for the physician to draw up a document himself might result in a more active 
participation of the physician. General objections have been discussed and overcome and 
the physician is committed to make an effort to follow the patient’s wishes. The physician 
is still able to return to this subject, but only on the basis of specific circumstances and 
not general objections. 
This incentive could be stated in a letter of intent for the physician; a letter in which the 
patient and the physician agree upon a commitment of best intents (Table 5.2). Of course 
there is never a duty to achieve a given result, but if a commitment of best intents is 
written down and agreed upon it is impossible for a physician to ignore the subject at a 
later stage. This is also the moment when the physician can explore the morals, values 
Table 5.2 Suggested content of the letter of intent 
1 Date of conversation: documentation of content of conversation
2 Statements about the fact that the physician will feel obliged and committed to this subject or 
refer the patient to a colleague if necessary.
3 Education of the patient by talking through the legal requirements
4 If and which persons will be involved when talking through the wishes
5 Exploration of values and wishes of the patient: which aspects of quality of life are crucial for the 
patient
6 Arrangements on recurrence (frequency) of this conversation and renewal of the advance directive
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and wishes of the patient and when the patient can be educated on the subject, about 
the restrictions and requirements of the law, about what to expect from his physician 
and how to keep the advance directive up to date. Physician and patient can have a 
conversation about response shift and how to handle it. They can make arrangements on 
how often they will discuss the advance directive.
When exploring the wishes and values of the patient, a physician will also talk about the 
subject of suffering, one of the requirements of the law (Penal Code art. 293 and Law on 
Review of Euthanasia and PAS).8 The concept of suffering is divided into two elements: 
unbearable suffering, which is a subjective opinion, and which must be understandable 
‘objectively’ for a physician and a lack of prospect of improvement.8 The lack of prospect 
of improvement is defined as the absence of acceptable treatment possibilities, the 
disease cannot be cured and symptoms cannot be relieved.8
The euthanasia law in the Netherlands is based (morally) on the principle of beneficence 
and (in terms of criminal law) the necessity defence. When a patient doesn’t ask for 
euthanasia, euthanasia is not allowed and subject to a murder charge. Physician integrity 
combined with the requirements of the law prevents euthanasia in cases of ‘tired of 
living’.8 When we look at HD, where all criteria for euthanasia can be met, it is the 
physician who eventually has to decide if the suffering is unbearable to such an extent 
that euthanasia is justified. The recurrence of conversation about the wishes of the 
patient, including his view on quality of life can take the physician along the way towards 
a desired end of life. The physician can signal a possible response shift. The professional 
integrity of the physician partly determines the scope of applicability of end-of-life 
wishes.14 By discussing and describing what is acceptable, the physician’s his frame of 
mind can partly be influenced, without the loss of professional integrity. 
conclusIon
Euthanasia and PAS are still matters subject to extensive discussion in The Netherlands. 
According to the physicians interviewed, euthanasia is an option patients should have 
when suffering from a neurodegenerative disease such as HD. Despite the fact that the 
respondents provide arguments for initiating a conversation about the options a patient 
has, most physicians do not take this step. In this article we suggest that there can 
be a legal, professional and moral obligation for a physician to talk about the subject, 
especially in the case of neurodegenerative diseases such as HD. The physician should be 
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aware of the fact that although euthanasia is not a normal medical treatment, it is part 
of his obligation to educate the patient about his disease and his prospects and it may 
be his responsibility to educate the patient about the possibilities of choosing the end of 
life. This obligation can be seen as a commitment of best intents, laid down in a letter of 
intent by the physician.
We suggest further research to be carried out into the wishes of patients, not only to 
improve treatment, but also to explore the expectations they have of their physician. 
We also suggest physicians be better educated about end-of-life wishes and the 
possibilities provided for in the law, thus assisting them in improving the way they help 
their patients to deal and cope with a devastating disease such as HD as well as other 
neurodegenerative diseases.
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Objective: To obtain in-depth information about problems physicians encounter 
when talking about advance care planning (ACP), in particular end-of-life wishes, 
euthanasia or physician assisted suicide (PAS), in patients with a neurodegenerative 
disease such as Huntington’s Disease (HD). 
Design and participants: Semi-structured interviews in 2011 with a purposive sample 
of 15 physicians familiar with HD; general practitioners, nursing home physicians and 
medical specialists.
results: According to the physicians, HD-patients increasingly show an interest in 
discussing end-of-life questions. We identified three patterns of how physicians 
evaluate decision making about the end of life. These patterns are based on 
different views on dealing with cognitive decline, psychiatric symptoms and signs 
and response shift. The evaluation and handling of these symptoms and signs in 
light of ACP proved to be specialty-specific and based upon a good and longstanding 
physician-patient relationship. ‘Admission to a nursing home’ as unbearable suffering 
elicits a different response from physicians in different specialties.  
conclusions: Loss of decision making capacities, psychiatric symptoms and signs 
and response shift are themes that apply to all physicians who are engaged in 
ACP in neurodegenerative diseases. The difficulties signaled and detected are not 
only applicable to physicians in the Netherlands, but extent to physicians in other 
countries as well when decisions for the end of life must be made. A firm and 
possibly longstanding physician-patient relationship with knowledge of a patient’s 
past, present, expected future and values and goals can be of importance for all 
physicians in decision making.
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IntrODuctIOn
Huntington’s disease (HD) is a progressive neurodegenerative disease, caused by an 
autosomal dominant inherited expansion of a CAG-repeat on chromosome 4. The disease 
is characterized by chorea and hypokinesia, psychiatric symptoms and progressive 
cognitive decline leading to dementia.1;2 There is no cure for this devastating disease and 
all patients eventually will become totally dependent for all daily life activities. Pneumonia 
is the primary cause of death, suicide is the secondary.1;3;4 The rate of suicide is 5-12 times 
higher compared to the general population.3-5 The prevalence of HD in the Netherlands is 
approximately 1,700. The estimated amount of persons at 50% risk is 5,000-8,000.
In the Netherlands euthanasia or physician assisted suicide (PAS) is legal under strict 
conditions after the euthanasia act was approved by parliament in 2002.6 Euthanasia and 
PAS are defined as death brought upon by a physician, only after a direct request from 
the patient. Parliament decided that euthanasia is not a patient’s right, but a request 
and a physician’s competence. The physician decides to either or not respond to the 
patient’s request.7 The first condition of the law on the legalization of euthanasia and 
PAS is that the request must be voluntary and well-considered. If a physician has doubts 
about these requirements, he is supposed to make extra inquiries and for example ask 
for a psychiatric consultation. This applies especially when there are problems with 
cognition, communicative impairments or a psychiatric disorder. The second requirement 
of due care is the requirement of unbearable suffering with no prospect of improvement. 
Unbearable suffering is ‘subjective’, it is the patient’s perspective that defines if suffering 
is unbearable. Whether the suffering is without prospect of improvement is also part of 
the medical expertise of the physician.7 Earlier research showed that patients put more 
emphasis on psychosocial factors of suffering, whereas physicians refer more to physical 
suffering.8 A difficult element regarding the element of unbearable suffering is the fact 
that it is subjective for the patient, but it must be ‘recognizable’ for the physician to some 
extent.9;10 The other requirements are extensively described in literature.6;7     
Between 6 and 10 requests for euthanasia or PAS in case of HD were granted in the 
Netherlands each year in the past five years.6 Besides clinical experience there are no 
studies on euthanasia or PAS or other end-of-life questions in patients with HD.
With an increasing prevalence of neurodegenerative diseases, and usually limited 
treatment options, possibilities to have a say in ones end of life, for example euthanasia 
or PAS could enhance patient’s quality of life and of dying.  
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The first aim of this study is to explore which problems physicians encounter when 
talking about end-of-life wishes, euthanasia or PAS with their HD patients. The second 
aim is to explore how physicians meet the wish of their patient, given that HD is a 
neurodegenerative disease characterized by cognitive decline and psychiatric symptoms. 
MEtHODs
The study consisted of semi-structured interviews with fifteen physicians who are 
experienced with the treatment of HD patients; four general practitioners (GP), two 
neurologists, two psychiatrists and seven nursing home physicians (NHP). Physicians 
were selected because of their knowledge of HD and were contacted by email. None of 
the contacted physicians declined. Interviews were conducted in 2011 and took place in 
their practice. Initial interview topics were formulated after examination of the relevant 
literature. Consistent with standard qualitative research techniques, the interviews 
were based on a topic list, which evolved as the interviews progressed through an 
iterative process to ensure that the questions captured all relevant emerging themes.11-13 
Physicians were interviewed based on the method of purposive sampling, the most 
commonly used form of nonprobability sampling.14 Sample size relies on the concept of 
“saturation” or the point at which no new information or themes are observed in the 
data. Saturation was reached after the 12th interview. All interviews were performed 
by the same interviewer and took approximately one hour to complete. The interviews 
consisted of questions concerning the presence of end-of-life wishes, the conversations 
between patient and physician about the end of life, why such questions emerged 
and the problems experienced with this subject, such as cognitive decline, psychiatric 
symptoms and response shift, i.e. adapting to the disease or deviating from anticipatory 
beliefs. The interviews lasted approximately one hour. 
All interviews were recorded, fully transcribed and subjected to qualitative analysis. 
As our study was explorative, we used open coding to identify relevant concepts. A 
second independent researcher read and coded all the interviews. The list of codes was 
discussed between the first author and the independent researcher. Examples of codes 
are cognitive changes, response shift, advance directives and reasons for thoughts about 
euthanasia by the patients and reactions from the physicians when these questions are 
asked.
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rEsults
All physicians had at least five years of experience in their field of expertise. Two GPs 
had a HD patient in their practice and performed euthanasia and two have a HD patient 
with whom they discuss the patient’s advance directive regularly. All but one of the 
nursing home physicians work or worked in specialized HD units of a nursing home. Three 
nursing home physicians had experience with performing euthanasia or PAS in HD. The 
psychiatrists and neurologists are specialized in HD (Table 6.1).
Conversations about end-of-life wishes
In general some of the respondents have noticed that questions regarding end-of-life 
wishes have been increasingly raised by patients in the last couple of years (Table 6.2, 
Quotation 1). One physician mentioned that end-of-life wishes have always been present 
in HD patients, but are more frequently discussed after the euthanasia law was passed. 
Respondents recognized two groups of patients. One group of HD patients does not think 
or speak about end-of-life wishes; the other is well informed on the subject and has 
thought about it before talking to a physician (Table 6.2, quotation 2-4).
table 6.1 Physician characteristics
Physician/Respondent Specialty Gender














15 NHP Female 
HD = Huntington’s Disease, GP = General Practitioner, NHP = Nursing Home Physician.
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How to recognize the patient’s wish in case of a neurodegenerative disease?
The physicians could be divided into three groups based on the responses regarding 
symptoms and signs of HD. The group of general practitioners represents the first group. 
When asked about cognitive changes and psychiatric symptoms and signs they indicated 
that they know their patient well and were able to determine if their patient was 
competent to make decisions. But they also mentioned that it is important to recognize 
and appreciate response shift over time (Table 6.3, quotation 1 and 2).
The second group of specialists (psychiatrists and neurologists) mentioned that when 
speaking with a HD patient it could be difficult to find out whether a patient is fully 
competent to express end-of-life wishes or whether the wishes are part of a psychiatric 
symptom such as depression or an obsessive thought (Table 6.3, quotation 3-5). 
Consequently, the value of the wish was questioned.
table 6.2 Conversations about end-of-life wishes 
1 R10: “With our new out-patient clinic, I think questions will be raised increasingly. Patients approach 
us: “I want to make amends for the future.”
2 R12: “Patients, who are able to think about the subject and have thought about the subject, start 
the conversation themselves.”
3 R7: “It is only a small percentage of patients that ask questions about the end of life.”
4 R11: “I notice that HD patients can be divided into two groups. The biggest group does not have 
a lot of understanding of the disease and disease awareness. And there are some people that are 
extremely occupied with this subject (red. Wishes for the end of life) and from those people I get a 
lot of questions or inquiries about euthanasia.”
table 6.3 Determine the patient’s wish: general practitioners and medical specialists 
1 R3: “She had always been clear, in every moment of choice and during the whole process of thinking 
about her wish.”
2 R4: “To clarify his wishes, that has been a long process and he is more aware of his wishes now. And 
he has been consistent in his wishes for such a long period of time, that I would be surprised if that 
would change. But we also talked about a possible change, to let him know he can change his wishes 
any moment.”
3 R5: “HD patients have difficulties to understand complex situations. A decision to opt for euthanasia 
and the process and procedures surrounding this choice are more difficult to understand for HD 
patients, in the stage when cognitive decline becomes clear. This is already possible early on in the 
disease.”
4 R7: “Compulsive behavior is also part of HD. The question is if the request for euthanasia really is 
well considered or if it is part of an impulse of the compulsive behavior.”  
5 R8: “If a patient, with a partly disturbed perception, in light of his disease wants to make a decision 
with grave consequences, then the question remains if a physician should intervene.”
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The third pattern was recognized within the group of nursing home physicians, who 
struggled the most with the value of the wish, competence and also with the value of 
the advance directives. They noticed that at the time of admittance the decision making 
capacity and competence had already diminished. Sometimes the admittance itself 
reflected a patients’ response shift (Table 6.4, quotation 1-4). In contrast to the GPs and 
specialists, NHPs first see patients in the latter stages of the disease. In general, advance 
directives are presented to them, sometimes by family members (Table 6.4, quotation 5). 
Neurologists, psychiatrists and NHPs agree with the option of euthanasia in HD, but 
consider the eventual performance as a task of the GP (Table 6.4, Quotation 6-7). 
However they acknowledged that a patient who expresses the need to talk about 
euthanasia or PAS shows some level of competence, which need should be appreciated 
and responded to accordingly.
Suffering
According to the law, suffering should be unbearable to warrant euthanasia or PAS.  
Most of the GPs could appreciate the wish of a patient for euthanasia in case of an 
unacceptable but inevitable move to a nursing home. Admission to a nursing home 
means for many patients full awareness of having reached the last stage of the disease 
table 6.4 Determine the patient’s wish: Nursing home physicians
1 R15: “If there is cognitive deterioration, there is a shift in the judgment upon what is acceptable. 
With a lot of people, things are never as bad as they seem. In a nursing home euthanasia is not often 
a subject. Patients changed and shifted so much already.”
2 R15: “Euthanasia is seldom performed. The main problem of the disease is the inability to make 
a plan. Important symptoms of HD are impulsiveness and behavioral disturbances and these 
symptoms can have a major impact on decision making capacities and competence.”
3 R13: “When a patient is admitted here, their cognition deteriorated to such an extent that it is 
almost impossible to find out what the wishes were. Or the cognition is intact, but there are so many 
psychiatric symptoms that that prohibits a clear request for euthanasia.”
4 R14: “Adaptation happens. You adapt to the situation. I can imagine that when it becomes 
impossible to stay at home, this is a next step of adaptation.”
5 R10: “Some have made an advance directive, earlier, with the GP, they show it to me….It is difficult, 
what is being competent, with this strange disease.”
6 R8: “I understand that patients would consider euthanasia. But I think euthanasia is something that 
belongs with the general practitioners.”
7 R6: “I think that a GP or NHP knows a patient better, knows the circumstances, so it is easier to 
concur with the situation of a patient.”
Chapter_6_Suzanne_zonderuitvullen.indd   87 11-9-2014   10:10:35
Chapter 6
88
with total dependency on others and no prospect of future improvement of the situation. 
Therefore, moving to a nursing home could qualify as unbearable suffering (Table 6.5, 
quotation 1 and 2). 
On the other hand all but one of the NHPs have the experience that the transfer of an 
HD patient from his home to a nursing home could ease some of the problems they 
encountered at home and result in a lessening of suffering. Medical specialist had more 
diverse opinions, both being able to qualify the admission as suffering or as an option to 
ease suffering (Table 6.5, quotation 3-5). 
table 6.5 Suffering, a different perspective 
1 R3: “Patients prefer to stay at home. And we try to make this possible with all kinds of care at 
home.”
2 R12: “I can imagine that a nursing home for some patients is unacceptable.”
3 R14: “As a GP you witness the disease process, in a nursing home we see the patient in an advanced 
phase. I believe that suffering is more visible for a GP and easier to understand.”
4 R8: “As a physician you have to understand what marks the end of adaptation for a certain patient. 
And for a general practitioner that can be easier than for a NHP. A NHP sees patients who are very ill 
and the reference for a GP is the fairly healthy human or patient.”
5 R9: “With a lot of people, things are never as bad as they seem. In a nursing home euthanasia is not 
a subject which is frequently brought up. Patients have changed and shifted so much already.”  
DIscussIOn
Physicians have observed that HD patients increasingly consider and accept euthanasia 
and PAS as an end-of life-option. Physicians are more open to respond to these 
considerations although they do not initiate with the exception of NHPs. All physicians 
distinguished between individuals who face their future disease prospects and wish to 
exert control over their lives, and those who avoid confrontation with the disease and 
live from day to day. GPs and medical specialists usually do not initiate a conversation 
about end-of-life wishes, contrary to NHPs who usually initiate conversations early 
after admission, with both the close relatives and the patients, where it is part of the 
procedure for advanced care planning (ACP).15;16 
Cognitive decline
When talking about ACP and wishes for the end of life, according to the law, a physician 
has to be certain that the request for euthanasia or PAS was voluntarily and well-
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considered.17 To evaluate if a request was voluntary and well-considered in case of 
a neurodegenerative disease such as HD, a physician has to take cognitive decline 
and psychiatric symptoms into account. Especially in neurologic diseases, such as 
HD, cognitive deficits, communication deficits and psychiatric symptoms may impair 
the ability of patients to decide upon wishes for the end of life, euthanasia or PAS.18 
Nevertheless patients want to make decisions for themselves regarding health care and 
treatment for as long as they can.19 Two main arguments are posed when considering ACP 
undertaken by a patient who loses capacities: 1) the patient who loses capacity is not the 
same person as the person who had capacities and 2) the patient with cognitive deficits 
still has autonomy and should not be held to previously expressed wishes.20-24 Besides, 
a change in previously expressed end-of-life wishes may also be explained by response 
shift.
Patients suffering from dementia will gradually progress and become less competent 
and lose decision making capacities as the disease progresses.25 On the other hand, 
other research showed that patients in the early stages of Alzheimer’s Disease are aware 
of their failing memory and are able to tell about their experiences with the disease.22 
Nevertheless the gradual progression allows the patient to adapt and adjust to the 
changing situation. This adaptation explains the second argument that because the 
patient’s personality changes, patients with cognitive deficits will not act in accordance 
with their earlier values and beliefs and thus should not be held to previously expressed 
wishes.22;26 This adaptation is part of what the process of response shift beholds. 
Recognizing response shift is important when talking to patients and about their 
wishes for the end of life and making a decision with the patient. The GPs in this study 
reported that they were able to recognize cognitive changes and response shift. The GPs 
recognized the phenomenon of response shift but also mentioned they could adequately 
respond to this, just because they know their patient well and usually have treated and 
supported their patient for many years. If a long physician-patient relationship preceded 
the decision about euthanasia or PAS, a GP will be able to tell if the decision was well-
considered and consistent. 
In contrast to GPs, other physicians in this study got involved with the care and treatment 
of the patient after the diagnosis had been made and guidance and treatment became 
necessary. They had a different physician-patient relationship (specialists) or were only 
involved in the last stages of the disease (NPHs). Knowing if the wish was well-considered 
and consistent was often difficult to find out and knowing if response shift had occurred 
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and the patient deviated from anticipatory beliefs proved difficult to determine, 
because of the missing longstanding physician-patient relationship. In case of HD these 
physicians mention cognitive decline and psychiatric symptoms and signs as difficult 
aspects to evaluate and to cope with when having conversations about ACP, euthanasia 
and PAS. Consequently, it was difficult to know if the present situation of the patient is 
compatible with a patient’s values and goals.27 Secondly, it was difficult to know if the 
present situation is the one for example previously talked about in the context of ACP or 
described in an advance directive, as was also described in a study about the sometimes 
problematic differences of views between physicians and family members/surrogates 
when making a decision for patients who have lost decision-making capacity.28 Other 
research also found that in patients with dementia the lack of key moments to initiate 
conversations about ACP, the patient’s lack of awareness of their diagnosis and prognosis 
and the fact that patients did not often initiate such discussions themselves were barriers 
to engage in ACP as a physician.29 
Psychiatric symptoms and signs
Psychiatric symptoms and signs were also mentioned as difficult aspects to cope with 
for specialists and NHPs when having conversations about euthanasia or PAS. HD is 
characterized by a broad range of psychiatric symptoms and signs including depression and 
suicidality.30 Research showed that particular appreciation of information is impaired in 
depression.31;32 Secondly there is a claim that talking about euthanasia or PAS with a patient 
suffering from psychiatric signs and symptoms reinforces loss of hope and demoralization. 
The argument states that by talking about euthanasia, the central element in the physician-
patient relationship is removed, namely the hope of improvement by treatment.33 In 
general, intervention to prevent suicide is indicated, because the wish for suicide can be 
part of a treatable sign. But sometimes a wish for suicide, and thus euthanasia or PAS can 
be reasonable. If the wish arises as a symptom of the disease itself, it is generally accepted 
that the disease should be treated. But if the wish is based on a rational evaluation of a 
patient’s past, present and future, a request can be reasonable.33 In HD most patients know 
about the development of the disease and their future prospects. Psychiatric symptoms 
and signs are part of the disease, but the wish for euthanasia or PAS can well result from 
their knowledge of the disease instead of their current psychiatric symptoms. From the 
answers of the NHPs we can deduct that distinguishing between signs of the disease and 
a rational evaluation of a patient’s actual state proves to be difficult. Again a longstanding 
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physician-patient relationship seems to be an important factor in dealing with psychiatric 
symptoms and signs and incorporating euthanasia and PAS in ACP. Guiding a patient 
for many years provides the opportunity to actually know the patient, his values and 
goals, to detect cognitive decline and psychiatric symptoms and signs and to discuss the 
consequences, relating to ACP and euthanasia and PAS, openly with the patient. 
Suffering
The specialists in our study could appreciate that a nursing home represents suffering 
and subsequently the wish for euthanasia. On the other hand several NHPs regard the 
admittance to a nursing home as a possible way of improvement of quality of life and 
thus as diminishing of suffering. Earlier research stated that working in a nursing home 
means that the perception of a life that is unacceptable or meaningful can change.34 This 
contrast can result in a different evaluation of a euthanasia request. The admittance to a 
nursing home may in itself also represent response shift and thus acceptance instead of 
suffering, which can be investigated by evaluating an advance directive, if present, and 
reports on the patient’s recent responses to the disease process. The GPs or specialist’s 
decision to qualify suffering as unbearable may be based on empathizing with the 
patient’s anticipated thoughts and feelings regarding admission in a nursing home.6 One 
may raise the issue that when distinguishing between these groups of physicians, part 
of the distinction is due to the fact the physician possibly agrees or sympathizes with 
the patient. That as a fellow human admittance to a nursing home would be undesirable 
and thus represent suffering.33 This might be different sometimes for NHPs. To try to 
avoid too much of a subjective judgement, the law provided several guarantees for 
these circumstances. First it is required that an independent second physician gets in 
contact with the patient and evaluates all the requirements of due care. Secondly the 
suffering must be unbearable to this patient. The patient’s history, past, values and goals 
determine if suffering is unbearable. Therefore, although a physician must recognize 
and emphasize with the suffering to some extent, physicians should realize that work 
environment can change their views, but not always the views of the patient. Suffering 
can be referred to as ‘increasing physical deterioration and dependency’ and ‘loss of 
dignity’.7;35 Moving to a nursing home can be the realization or materialization of ‘loss of 
dignity’ and ‘total dependency’, thus of suffering, for some. Moving to a nursing home 
can be a practical solution for a need, without offering a real improvement of quality of 
life, thus without changing the views of the patient.
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A limitation of this study is the relatively small number of physicians interviewed which 
were selected in advance. On the other hand, this is more of a problem for quantitative 
than for qualitative research, as the use of purposive sampling allowed us to possibly 
detect all relevant themes without looking for a representative sample of the profession 
as a whole. 
Advance care planning, including euthanasia and PAS can be difficult topics for physicians 
to initiate, evaluate and talk about with patients. A second limitation could be that we 
explored opinions of physicians about these topics, what they experience and what they 
say about the topic, instead of what they actually do. But talking about these topics 
revealed the problems they encounter, but moreover the problems they suspect or think 
are present. By exploring and recognizing these problems, we are be able to signal the 
issues and propose solutions for physicians to overcome these issues and to possibly 
diminish the struggle with topics such as cognitive decline, response shift or the judgment 
upon suffering. 
We argue that the loss of decision making capacities, psychiatric symptoms and signs 
and response shift are themes that apply to all physicians who are engaged in advance 
care planning in patients with neurodegenerative diseases. Secondly we argue that the 
difficulties signaled and detected are not only applicable to physicians in the Netherlands, 
but extent to physicians in other countries as well when dealing with patients that 
have a disease where decisions for the end of life must be made. A firm and possibly 
longstanding physician-patient relationship with knowledge of a patient’s past, present, 
future and values and goals can be of importance for all physicians in decision making.
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In The Netherlands euthanasia and physician-assisted suicide (PAS) have been legal 
since 2002 albeit under strict conditions.1-3 This enabled patients who were suffering 
from a neurodegenerative disease, such as Huntington’s Disease (HD), to make plans for 
the future. In our out-patient clinic specialized in HD we have experienced an increase 
in the number of requests for euthanasia and the use of advance directives. Further 
investigation has revealed that many HD patients and identified gene carriers do have 
some ideas about what they want regarding the end of their life.4 We then wondered 
if physicians in other European countries, who are familiar with HD, have made similar 
observations and whether they are willing to discuss the subject with their patients. We 
were also interested in the actual content of the patients’ wishes and what the physician’s 
reaction is to these or related questions. 
In an attempt to gain insights into the European perspective, we developed a 
questionnaire which we sent to participants/investigators/physicians who participate in 
the European Huntington’s Disease Network (EHDN). 540 questionnaires were sent out 
in February 2013 and a reminder in April 2013 to participants in 17 European countries, 
all by email. The questions addressed the end of life options and aimed 1. to investigate 
if physicians know about these options in their country, 2. to investigate if physicians ever 
have conversations with their patients about their wishes regarding the end of life and 
3. what their opinion is about the possibilities in their own country. In addition, some 
biographic and demographic data were collected.  
Only 53 questionnaires were returned, i.e. a response rate of 10%. Another 10 
respondents indicated that they did not want to complete this questionnaire or 
participate in this study, for different reasons: lack of time, lack of interest, not enough 
contact with HD patients or not willing to participate because of the nature of the topic. 
Due to the low response rate, we cannot draw any firm conclusions, but we will make 
some general comments and wish to speculate on the reason for the low response.
The responses were derived from physicians in 15 European countries. Forty respondents 
were neurologists; just over half considered themselves to be religious. Most respondents 
answered that advance directives concerning: not to resuscitate (DNR), treatment 
limitations or the appointment of a representative are valid in their country. 
Half of the respondents, representing 12 European countries, reported that their patients 
do express wishes for the end of life. These involved all aspects of care, administration 
of fluid and food, admission to a hospital or nursing home, DNR and euthanasia and PAS 
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in countries where it is legal (The Netherlands, Belgium, Luxemburg and assisted suicide 
in Switzerland). In the majority of cases the patient or a relative took the initiative to 
discuss the wishes with the physician. In a minority of cases the physician actively asked 
the patient about his/her thoughts and feelings about the end of life. Physicians reported 
that the reasons for having these wishes were related to fear of future suffering, having 
witnessed suffering in a relative, and the fear of loss of control, independence and dignity. 
Most patients were in the early or advanced stages of the disease when the discussion 
about their wishes for the end of life took place.
Considering the management options for the end of life some respondents reported that 
“quality of life could also mean quality of dying, and thus, euthanasia or PAS”: several 
other respondents indicated that their focus is on quality of life. “I am against any kind of 
assisted suicide as this is a reflection of giving-up, or an example of a missed diagnosis. 
It is far from my professional attitude to let an event like that pass” and “I’ll fight for the 
health of my patients and their quality of life. I’ll never take someone’s life.” For these 
respondents, assisting in euthanasia or PAS is not an option. 
Several respondents indicated that they would like to see management options for 
patients being expanded in the future, because patients do have end-of-life wishes. It 
would seem, however, that others ignore this fact. “It should be recognised by our law” 
and “I hope that our law could change. They ignore the problem, but these patients exist” 
and “there is a strong opposition from some sectors of the society, such as the church.” 
One physician expected “there would be a decrease in the number of suicides in the HD 
population if wishes for end of life could be expressed and euthanasia or PAS legalised.”   
Reviewing the responses we did receive, we can only speculate about the reasons for 
not being willing to participate in this study. From the questionnaires returned, we 
can deduce that many physicians probably do get questions from patients about their 
choices for the end of life, treatment limitations and retaining a certain quality of life. 
Perhaps the nature of the questionnaire was too delicate, although we did not direct our 
questionnaire towards euthanasia and PAS solely, but towards wishes for the end of life in 
a broader perspective. It may be that talking about euthanasia, PAS or other life-limiting 
actions is still difficult in parts of Europe, but we feel that our questionnaire was drafted 
in such a way as to invite physicians to talk about wishes for the end of life in general. 
A second reason could be that physicians perceived it to be not important or irrelevant 
to their practice to answer. Other studies asking about practices surrounding the end 
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of life in general reported higher response rates.5;6 None of these studies were directed 
towards a specific disease. A reason for a higher response rate in one study could be 
that physicians in this study were selected because of their involvement in the treatment 
and death of a specific patient instead of our choice to send the questionnaire to every 
physician treating patients with HD and asking general questions about the end of life. 
Some physicians may consider that it is not part of their professional duty to talk about 
care at the end of life. But, is it not the responsibility of the physician to care for his 
patient until the end of the disease? Is caregiving not always synonymous with quality of 
life which can also mean quality of dying for an individual patient?7-9 As some physicians 
say: “I am always glad when the patients are admitted to a nursing home, then I do not 
have to discuss the end of life issues.”  
A third reason might be that physicians receive many requests by email. However our 
study group was not randomly selected, but approached because of their involvement 
with HD, their participation in HD research and their membership of EHDN. From this 
point of view it is even more remarkable that response rate was so low, which could 
support our hypothesis that the issue might have been too delicate. 
Ways to improve response rate could be for example to hand out the questionnaire 
during the international congresses on HD and ask physicians to fill in the questionnaire 
during the congress.
From our studies we concluded that HD patients do have wishes and do want to talk 
about their wishes with their physician.4 Talking about thoughts and wishes for the end 
of life and talking about quality of life and all that quality of life encompasses can be very 
helpful and reassuring for patients.10 As patient’s autonomy attracts an increasing amount 
of attention in the public debate, choosing not to be treated will become part of doctor-
patient conversations.11 Studies have shown that families rely on physicians to help in the 
decision-making process.11 A research paper reported that patient autonomy could even 
be transferred to the physician when the patient was no longer competent according to 
the family.12 Furthermore, other research has indicated that some form of acceptance and 
regulation of euthanasia and physician-assisted suicide is gaining increasing support from 
the general population in most western countries.13
Are we expecting too much at this moment by drawing attention to this topic or should 
doctors prepare themselves better for this conversation with their patients? Thus are 
we expecting that we can ask these kind of questions to physicians in other countries, 
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because we are so used to talking about this topic and discussing these wishes in The 
Netherlands? Is the time not there yet, is it too soon to ask questions about this topic 
to physicians in other countries, should we wait a couple of years? Or should doctors 
consider taking care of their patient in all aspects of their disease, the patient’s welfare 
and best interests, including quality of dying, as part of their job? 
In our opinion doctors will receive questions from patients about this topic more 
frequently in the near future. Other studies already concluded that physicians with 
training in palliative care were more inclined to make end-of-life decisions.6 We do 
not suggest that other countries should legalize euthanasia or PAS in the near future. 
Nevertheless, the first step towards helping patients is to make the topic of end-of-life 
wishes open for discussion. We think that the awareness that HD patients have end-of-life 
wishes and the awareness that a physician and patient (together) should make end-of-life 
decisions, can increase the realization that this is indeed a very relevant topic for every 
physician treating patients with HD and thus to respond to these kinds of questions. 
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Focus of this thesis
Even before the media attention for this topic, euthanasia and end-of-life care in 
Huntington’s Disease (HD) seemed to attract the attention of patients and families and 
became a subject several patients wanted to discuss.   
Therefore the aims of this thesis were I) are end of life wishes present in patients with 
Huntington’s disease and known gene carriers, II) are patients willing to discuss these 
wishes, III) what is the content of these end-of-life wishes; IV) do physicians actually 
discuss wishes for the end of life with their patients and V) how do physicians cope with 
these issues and questions. In this final chapter an overview of the main research findings 
is presented and discussed. 
Subsequently a few key issues on the law on euthanasia and physician assisted suicide 
(PAS) in The Netherlands are reflected upon; advance care planning and the usefulness 
of advance directives with special attention for a progressive neurodegenerative disease 
such as HD. We focus on two key signs of HD, namely cognitive decline and psychiatric 
symptoms, which present specific difficulties when thinking about euthanasia or PAS and 
when trying to fulfil a patient’s wish. 
Main findings
Following a study of the recent literature, the law on euthanasia, the development of the 
law and the applicability of euthanasia in HD is reviewed (chapter 2). The development 
of criminal court decisions in the context of social history, and the increasingly recognized 
patient rights and right to decide about one’s own life without leaving it up to the 
physician, led to the implementation of the ‘Law on review on the ending of life on request 
and assisted suicide’ in 2002. The fact that HD is an inherited disease and persons at risk 
can be tested early in life with a accuracy of nearly 100% led to the situation that patients 
want a say in their future, their life and therefore also their death. The exploration of the 
legal possibility of euthanasia in HD patients showed that euthanasia is very well possible 
in patients who are affected by this neurodegenerative disease despite the fact that all 
patients will suffer from dementia at some point in time. An advance directive, advance 
care planning and repeated conversations with the physician are of great importance. 
The importance of keeping the shared opinions and values -and their notification in the 
patient’s medical record- up to date seems somewhat neglected by physicians sometimes.
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The wishes of patients
The results of one of the main questions of this thesis and the reason for starting this 
study are described in chapter 3 and 4. During the interviews with an unselected group 
of patients we discovered that asking questions about the end of life is not considered 
a burden. In general patients reacted positively and were willing to comply. One of the 
main findings is that there are probably more patients who think about the end of their 
life than is currently known to physicians. Although the qualitative approach only let us 
discover themes, a remarkable finding was that patients think about the end of life, but 
have not always talked to their physician about it. Reasons for this restraint were that 
end-of-life wishes were not yet clear to the patient and that the patient only had some 
general ideas about what he/she wanted to prevent of avoid, but these thoughts were 
not explicit yet. Furthermore and possibly because of this somewhat ambivalent attitude 
towards the subject, there is a lack of knowledge about the legal and practical possibilities 
and requirements. 
The themes described in chapter 3 about the presence of wishes and the lack of 
knowledge were further explored with a qualitative study. Possible influences of patient 
characteristics and disease characteristics which were not detected by our qualitative 
study were further investigated. These characteristics include age, gender, religion, 
education and disease stage and were investigated by the use of a questionnaire. The 
results are described in chapter 4. Out of 249 patients that were approached and 
received a questionnaire, we got only one explicit negative reaction. One-hundred-and-
thirty-four patients returned their questionnaire and we did not receive a response from 
114 patients. Our research showed that thinking about the end of life as HD patient or as 
a premanifest gene carrier is not restricted to advance disease state, but is something of 
all stages of the disease. Patients have thoughts about their end of life. These thoughts 
are sometimes just confined to wishes about how to organize care in the future, but many 
times thoughts are directed towards how to have a say in the end of life or to determine 
one’s own end of life. Presence of wishes was not correlated to any demographic 
characteristic. The only patient characteristic that was correlated with wishes for the end 
of life was knowledge about the disease and future prospects based on experiences with 
family members who had or have this disease. 
There was only a minor group of patients who have an advance directive. We can only 
speculate about the reason why, but derived from our qualitative research, a hypothesis 
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could be that thoughts about the end of life are maybe just thoughts at some point in 
time and not yet conclusive enough to be written down and documented. 
The role of a physician 
The results and interpretations of the qualitative interviews with the physicians are 
presented in chapter 5 and 6. The results showed that the physicians are open and willing 
to talk about the subject, but leave it up to the patient to enter into such a conversation. 
The requirements of the law are usually known but remain somewhat theoretical. The 
use of advance directives, the task a physician has when exploring wishes for the end 
of life with patients with a neurodegenerative disease and the implementation into 
everyday practice proved to be difficult. During analysis of the interviews some themes 
were recognized that can only be discovered with qualitative techniques, such as the 
evaluation of suffering of a patient, how to handle response shift and the different 
opinion upon a professional’s task when entering into a conversation about the end of 
life. 
These findings gave the opportunity to suggest the use of an instrument to help a 
physician in guiding the patients. The instrument is the use of a letter of intent. In that 
letter a physician writes down the request of the patient and declares it to be his intent 
to help the patient in due course with the fulfillment of the wishes. The intent shows that 
a physician will take the request serious, without promising to reach the result wished 
for. An important part of the letter consists of the description of the wishes of the patient 
and the frequency upon which the conversation will be repeated. The document can also 
be used to educate the patient further upon the requirements of the law; to make sure 
the patient does not assume things are taken care of after writing and filing an advance 
directive. The letter of intent also reassures an active role of the physician. Because even 
though applicable situations are recognized, especially by nursing home physicians, the 
advance directive is sometimes declared inapplicable. In these cases the physician is not 
able to tell if the situation the patient is in now, is the one mentioned and referred to in 
the advance directive. Secondly the physician is not convinced of the suffering and of the 
fact that this is really what the patient wants. Taking a more active role and entering into 
conversations about the end of life can make complying with an advance directive easier. 
It can prevent suffering by the patient.
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European physicians familiar with HD asked about patients’ wishes for the 
end of life  
The last part of the study was to explore if physicians in other European countries also 
perceive that end-of-life wishes are present in patients with HD and if physicians discuss 
these wishes with HD patients (chapter 7). We developed a questionnaire and sent it to 
European physicians, members of the European Huntington Disease Network (EHDN). 
Unfortunately the response rate was very low. We can only speculate on the reasons 
for this low response rate. One can be that physicians are tired of questionnaires and 
decided not to answer. A second can be that this is not a topic that is of importance for 
HD patients in their country. Thirdly, it is possible that physicians try to avoid this topic, 
because of its illegal status in their country or because they think it is too difficult a topic 
to enter into with patients.   
From the returned questionnaires we can draw only minor conclusions. We received an 
answer from every European country participating in EHDN. This gives us a fairly general 
insight into the possibilities for the end of life and possibilities to talk about, write down 
and respect end-of-life wishes for HD patients in each country. The responses showed us 
that in other European countries wishes for the end of life exist in patients and patients 
discuss these wishes with their physicians. We concluded that as physicians we cannot 
ignore this topic and with more and more patients practicing and demanding their 
autonomy we will probably be increasingly confronted with discussions of this kind.  
Euthanasia in advanced Huntington’s Disease
Reports on performed euthanasia and PAS increase each year in The Netherlands.1 Two 
main categories of diseases attract the attention of the general public and politics in the 
debate about euthanasia in recent years: psychiatric diseases and dementia. The Regional 
Review Committees for euthanasia (RRC) publish their findings and core cases every 
year and pay extra attention to euthanasia in case of an underlying psychiatric disease or 
dementia more frequently.1 
Huntington’s Disease (HD) has features of both, psychiatric signs and symptoms and 
cognitive decline leading to dementia. In 2012 an interesting case was reported to the 
RRC, that attracted a lot of attention of the general public and in the media. In this case 
a general practitioner reported to the RRC about euthanasia in a patient diagnosed with 
HD. Six years earlier the patient had talked to her general practitioner about euthanasia 
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for the first time. She signed an advance directive. She also talked to her family about her 
wishes and appointed her husband as her legal representative in case she was not able 
to express her wishes anymore. In the years that followed the patient and her physician 
did not regularly talk about euthanasia or the advance directive. Four years after the 
first conversation the general practitioner wanted to talk with her about euthanasia 
again but the patient ended the conversation quickly saying she didn’t want an injection 
at that time. Two years later communication was hardly possible anymore. During her 
last visit to the outpatient clinic of her neurologist the patient uttered only one word, 
‘euthanasia’. When the subject of euthanasia was brought up by the general practitioner 
later the patient did not react or respond. Finally her husband asked for euthanasia 
and the request was honored. The RRC concluded that since several years had passed 
between the first conversation about euthanasia and signing of the advance directive and 
the impossibility of conversation six years later, the general practitioner should not have 
come to the conclusion that the request for euthanasia was made voluntary and well 
considered. Secondly, although the patient had declared, also in writing, that admittance 
to a nursing home would be unbearable for her, it seemed the patient was reasonably 
content during the days she spent in a nursing home. Thus the physician could not 
conclude that the patient was suffering unbearably.1 
In that same year a second case of euthanasia in a patient with advanced dementia and 
based on an advance directive was reported to a RRC. In this case the RRC concluded that 
the euthanasia was carried out within the limits set by the law because the patient spoke 
repeatedly about euthanasia with her physician, could well describe what unbearable 
suffering meant to her and made it clear to her physicians and others, both verbally and 
non-verbally, that she wanted to die.1 
The difference between these two cases was the possibility of conversation between 
patient and physician and the fact that conversation about possible euthanasia 
occurred only a few times in the case of the first patient and repeatedly in the second. 
The comments of the RRC in these cases provide further clues and help for physicians 
discussing euthanasia with patients suffering from dementia, and it helps deciding if 
possibilities exist for euthanasia in case of dementia, based on an advance directive.  
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What euthanasia actually beholds: anticipating the future
As described briefly in chapter 2 the debate about euthanasia in The Netherlands has 
been going on since the 1960s. In the early eighties some physicians started to report that 
they had performed euthanasia and the chief public prosecutor decided to bring some 
of them to court to produce clarity and judicial rulings with which to go forward. Several 
key cases have been brought to the Hoge Raad (Supreme Court) since then, clarifying 
the requirements of due care and setting boundaries as to the scope of the possibilities 
physicians have.2
The first ruling where a verdict is asked of the Supreme Court in case of death on 
request is the verdict in the case of dr. Postma in 1973.3 This was the earliest case in the 
development of Dutch euthanasia law, but was one of ‘private’ assistance. The physician 
who carried out the euthanasia was not the patient’s treating physician but the daughter 
of the patient. In this case the father of the daughter/physician died after a long period 
of suffering and the mother/patient decided that she did not want to die that way. The 
mother/patient suffered from several somatic illnesses, was admitted to a nursing home 
and eventually also became depressed. The depression proved to be hardly treatable 
and rehabilitation failed. The mother/patient tried to commit suicide and in the end the 
physician/daughter decided to help her mother. 
There are many differences between this case and the requirements of due care that are 
requested now-a-days, which are elaborated in rulings of the Supreme Court in the years 
that followed.  
The second and most important case to set the framework of requirements of assisting a 
patient to die on his request is described in chapter 2 and is the case of dr. Schoonheim 
in 1984. In this case the Supreme Court ruled that euthanasia could be legally justifiable 
under specific conditions.4 We described these conditions in chapter 2. 
A third interesting case when reviewing the possibilities and the boundaries of the 
possibilities provided for in the law, was the case of senator Brongersma.5 During the 
last years of his life, Brongersma was diagnosed with several illnesses and discomforts, 
all by themselves not life-threatening, but negatively influencing his quality of life. He 
had a depressed mood, but was not diagnosed with a depression. He repeatedly asked 
his general practitioner to help him to die and in the end the general practitioner did. 
The Supreme Court however ruled that the general practitioner did not act within the 
scope of the limits set by the court rulings of the past years. Reason for the rejection 
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of the appeal to necessity was that the specific conditions that make euthanasia 
justifiable do not apply to situations where the suffering is not predominantly due to 
a medically classified illness, either somatic or psychiatric. One of the requirements 
is that the physician should act according to scientific medical views and insights and 
ethical standards of the profession. In case of a request for euthanasia without a medical 
classified illness a physician does not act according to these requirements, because the 
expertise of a physician is limited to the medical domain and does not extend to more 
general questions of life and death.6
Reflecting on these three important cases and the considerations of the Supreme Court 
and the development of the euthanasia law and practice in The Netherlands we can ask 
ourselves what the meaning of euthanasia actually is for patients. The word euthanasia 
comes from the Greek word ‘ɛύθανατος ‘, meaning a good death. The patients in the 
cases of dr. Postma and dr. Schoonheim both anticipate upon future suffering and 
asked for a good death, without further suffering. When thinking about the request for 
euthanasia or PAS, could we not come to the conclusion that euthanasia or PAS mostly 
is about anticipating and avoiding future or imminent suffering? Because when somatic 
suffering is present, a physician has its options, ways and tools to relieve that suffering. 
When a patient is in pain, is short of breath or uncomfortable physicians have medication 
to relieve suffering, without talking about euthanasia or PAS. Most physicians can use 
palliative sedation to relieve signs and symptoms of disease. Sometimes these kind of 
treatments may lead to an earlier death, but that possibility was not intended and the 
treatment was not started to hasten death.  
Thus when somatic suffering can be relieved, why do we need euthanasia and PAS? In our 
opinion we need euthanasia and PAS because they represent an option for patients to 
avoid suffering, to not come to the stage where suffering must be relieved for example by 
inducing a reduced consciousness and to provide a possibility to stay in control of one’s 
own life. Thus to avoid suffering and stay in control, a patient anticipates the future. 
If we accept this conclusion that euthanasia and PAS are to anticipate future suffering, it 
brings us to several interesting topics. First the advance directive. The advance euthanasia 
directive is developed to anticipate future suffering. But are we then anticipating to the 
anticipation of future suffering? Secondly, the meaning of the second article, second 
paragraph of the euthanasia law in The Netherlands, stating that in case of an advance 
directive, the other requirements of due care are accordingly applicable. And a third topic 
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can be the wish for euthanasia in case of dementia. Is a patient able to anticipate future 
dementia?      
Anticipating future suffering
Suffering is understood and interpreted differently in different contexts. In palliative 
care the prevention of suffering and the relief of suffering is a major goal.7 The origin of 
suffering is different for patients suffering from different diseases. For cancer patients and 
patients with heart failure suffering is related to somatic complaints. For patients with 
amyotrophic lateral sclerosis suffering beholds fear of suffocation and dependency.8 For 
HD patients a reason to ask for euthanasia is fear of dependency, dementia and future 
signs and symptoms of the disease, usually after having witnessed a family member 
(chapter 3 and 4). For laypeople the concept of suffering usually conjures images of 
patients with pain.9 Suffering is seen and dealt with in many different ways and people 
who suffer are understood in different ways, for example: suffering is part of life, or 
people who suffer are without hope, waiting to die, or that allowing people to suffer is 
wrong and the ending of suffering is a right.7 The way we perceive suffering as individuals 
will probably also decide how we cope with suffering and how we anticipate on future 
suffering. The avoidance of suffering has been used as an argument for the legalization of 
euthanasia and physician assisted suicide. 
Competent patients are seen as autonomic individuals, capable of making their own 
medical decisions, including decisions about medical treatments and also death, instead 
of patients listening to physicians and following their physicians’ decisions.10;11 Dignity is 
associated with independence and preserving one’s intellectual powers.12;13 Recognizing 
each competent individual as capable of making their own autonomous decisions is 
one of the key constituents of modern Western medicine. A patient can make his own 
decisions, whether the doctor agrees with the decision or not. Autonomy and dignity 
as concepts led in the medical domain to the fact that patients wanted a say in their life 
and death, wanted to control the end of life and this process became part of self-identity. 
Deciding when it is time to die became part of dying in accord with the individual’s 
personal way of living. The fear of losing dignity and autonomy are earlier described as 
reasons for asking for euthanasia in time.12;13 Furthermore, another study showed that 
when asked, depending on others may be perceived by older persons as problematic and 
socially as being a ‘burden’.12 
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This fear can only be understood as fear for the future, fear for future dependence and 
loss of dignity, fear of not being able and capable to make decisions anymore. But if this 
fear for these future possibilities is a reason to ask for euthanasia, we can come to the 
conclusion that asking for euthanasia means anticipating future suffering.
Advance directives and euthanasia in the Dutch law
Euthanasia based on an advance directive remains one of the most debated topics of the 
law since the law passed in 2002. The law on euthanasia and PAS and the legalization of 
those acts by a physician states in the second article paragraph 2 that euthanasia and PAS 
are possible, based on an advance directive, replacing a direct request, taking the other 
requirements of due care, which are accordingly applicable, into account. But what does 
accordingly applicable means when we describe euthanasia as anticipation to future 
suffering and an advance directive as anticipating to the anticipation of future suffering?
As described extensively in literature the first requirement for a physician to explore 
is if the request is voluntary and well considered.14 When a physician discusses the 
advance directive with the patient at the moment it is filled out, he can explore these 
requirements.15 This may not always be done. As we described in chapter 3 patients 
are not always aware that when following the law, it is the physician who is leading in 
the process that leads to euthanasia. It is the physician who has to be convinced that 
there is no other possibility to relieve suffering and no other solution in this case than 
euthanasia. Patients are not always aware that the physician must be part of the process 
of determining wishes for the end of life and filling out an advance directive. 
When the advance directive is not discussed when it is filled out, the physician can have 
the opportunity to discuss the advance directive when it comes to his attention that 
an advance directive is present. The physician thus explores and knows the will of the 
patient, knows that the request is well considered and voluntary at that moment. But 
how can a physician decide if euthanasia or PAS still is the wish of a patient, for example 
10 years later? Parliament decided that the advance directive reflects the will of a 
patient, the past will of the patient is ‘translated’ into the present. In order to know and 
understand the will of a patient, the advance directive must be explicit and signed and 
dated by the patient.16 Parliament also stated that if all requirements of due care were 
met, a physician can still decide not to go forward with the requested act, because of 
well-founded reasons, for example the state of medicine now offers more possibilities 
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that those that were present at the time of signing the advance directive. The physician 
is expected to imagine what the will of the patient would have been in these changed 
circumstances.16 This example is a somewhat strange one and shows overlap with 
the fourth requirement, but was meant to support the reasoning of Parliament that 
a physician can always decide not to go forward with the requested euthanasia. The 
fourth requirement of due care states that no reasonable alternative exists in light of the 
patient’s situation. If new treatment possibilities exist , reasonable alternatives could 
also be present and thus the other requirements are not accordingly applicable in such 
a situation. We conclude that this example represents some of the difficulties that arise 
with this paragraph of the law. 
‘Accordingly applicable’ or applicable in a corresponding way
If we assume a physician is able to know the will of the patient (now and in the future), 
we turn our attention towards the other requirements, which are ‘accordingly applicable’ 
or applicable in a corresponding way. The second requirement is the requirement of 
unbearable suffering without prospect of improvement. Severely demented patients are 
generally believed not to suffer from their condition, according to the Ministers of Justice 
and Health and according to current scientific standards.2;12;17 This second paragraph 
was even considered an empty shell, especially for patients suffering from dementia, 
for whom it was largely intended, because of the fact that the other requirements could 
not be met.2 Nevertheless parliament stated that the advance directive can serve as a 
guidance for a physician when confronted with a patient who is no longer able to express 
his will. A physician could and should however always make his own judgment.16 
Knowing the position of Parliament we turn our attention towards the phrase ‘accordingly 
applicable’ or applicable in a corresponding way. Parliament does not take a position 
upon this phrase other than that a physician should consider the possibilities and make 
his own judgment. But when should the other requirements be accordingly applicable? If 
we accept that euthanasia is anticipating future suffering, the suffering must be described 
in the advance directive. The patient must have anticipated what he feared and expected 
that to be unbearable. Anticipating the future does not take the possibility of response 
shift into account. We wrote about response shift in chapter 6.
Furthermore what does accordingly applicable mean in the context of the requirement 
that ‘the physician informed the patient about his situation and his prospects’ when 
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communication is no longer possible? The patient can be informed when he writes 
down his wishes and when he draughts his advance directive. If the situation changes 
in the following years, the advance directive can be adapted to this new situation. But 
what if the advance directive can no longer be adapted, because the patient is no longer 
aware of his situation or no longer capable to express his awareness of his situation, as is 
possible in advanced HD?
Parliament again did not take a position upon the difficulty with this problem, but I 
believe that some solution is provided in the explanation of the use of an advance 
directive. The past will of the patient is ‘translated’ to the present. By talking with the 
patient regularly about his situation and prospects, a physician is able to know the will 
of the patient and the consistency of the will. And if the situation changes he can try to 
extrapolate the will of the past into the future and decide what this new information 
would change about the situation and the prospects. 
The same explanation holds for the requirement that patient and physician together 
should come to the conviction that there is no reasonable alternative in light of the 
situation. The physician and patient have talked about the situation repeatedly and 
together decided that, in due course, euthanasia or PAS was going to be the only possible 
solution. When communication is no longer possible, it is difficult, not to say impossible, 
to come to this conviction together that euthanasia or PAS is the only possible solution, 
but again the physician can follow up on his experiences from the previous period. In this 
situation the information of relatives can also be informative and important, even though 
a physician cannot act solely on the basis of information from relatives.
The fifth requirement of the law states that an independent second physician must 
visit the patient and give a written opinion on the due care criteria. It seems difficult 
to evaluate these criteria for an independent physician, when he meets the patient at 
a moment in time when communication is hardly possible or dementia has progressed 
to a stage where a conversation about the voluntary and well-considered wish and the 
content of unbearable suffering is hardly possible because of cognitive deficits. 
A possible solution lies in the relationship with the patient and the anticipation upon the 
request by the first or ‘performing’ physician. This second physician maybe less able to 
translate the past will into the present when he meets the patient at a late stage in the 
process. However when physician and patient anticipate a future request for euthanasia 
they can anticipate on this requirement as well by asking the independent physician to 
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visit the patient early and give his written opinion in an early stage. At present, current 
rulings of the RRC state that the report of the second physician has limited shelf life 
and an early consultation cannot replace a later one. However if this second physician 
repeatedly visits the patient a firm and thorough dossier will be available. With this 
dossier a RRC can follow the line of reasoning of both the first and second physician. A 
RRC can evaluate and make a substantive assessment of the performed euthanasia or PAS 
and the criteria of due care. 
If we read the requirements very strictly, one may argue that the accordingly applicable 
requirements only apply to the suffering without future prospect of improvement and the 
voluntary and well-considered request. The requirements of informing the patient about 
his situation and prospects and being convinced there is no reasonable alternative in light 
of a rapidly changing medical science and rapidly increasing treatment possibilities seems 
difficult to adhere to and to anticipate in the future. Secondly the consultation of an 
independent second physician who should give a written opinion on meeting the criteria 
also seems difficult to make ‘accordingly applicable’ when communication is no longer 
possible. On the other hand, looking at the explanation of Parliament and reasoning in 
light of their thoughts, Parliament did provide space for a physician to interpret and judge 
every case individually. Anticipating and extrapolating the past wishes of a patient into 
the present situation, anticipating future suffering and a future wish for euthanasia by 
preparing everything in advance, when trying to find an acceptable solution for a patient, 
a physician enters a domain where he can act, but where the law is stretched to the limit. 
Solutions are available, but must be carefully weighed and extensively discussed with all 
parties involved. Reaching the limits of the law, stretching these limits and being aware of 
this process can only be allowed when the process and the action are checked, balanced, 
controlled and judged upon. We find ourselves in a transition from law towards ethics.
Recent developments in the debate about euthanasia in case of dementia, 
based on an advance directive
The Health Council of The Netherlands concluded already in 2002 that dementia alone is 
not enough ground for euthanasia. Main difficulties that were recognized and described 
were 1. the difficulty to decide when a patient is incompetent and lost its decision 
making capacities to such an extent that the present acts of will should be ignored in 
favor of the advance directive and 2. if patients with dementia actually suffer unbearably 
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and hopelessly. A third recognized but not mentioned dilemma by the Health Council 
is the absence of a physician-patient relationship and conversation about the wishes 
when a patient is in an advanced stage of dementia. Several groups then proposed to 
shift attention towards the early stages of dementia. However, as prof Hertogh stated, 
a patient suffering from dementia has two options: “either deny what is happening and 
loose contact with reality or face the reality and realize that he/she is losing oneself.”18;19  
In 2012 the Royal Dutch Medical Association (KNMG) published its sharpened position in 
the matter of euthanasia in dementia, based on an advance directive.20 The KNMG stated 
that without communication euthanasia is impossible. The physician of the patient and 
the independent second physician should both evaluate the request for euthanasia and 
communicate with the patient about his wish, suffering and alternatives. The sharpened 
position of the KNMG ‘adds’ to the law the requirement of communication whereas 
the law only states that an advance directive can replace the expressed request.21 As 
discussed earlier we recognize the difficulties with advance directives and the phrase 
‘accordingly applicable’ in the law, however we feel that with this position the KNMG 
ignores the possibilities provided for in the law, for example role and function of the 
independent second consultation of a physician, which is to investigate and form his 
opinion on requirements of due care and not to agree with the performing physician or 
consent. We also proposed a possible solution in the previous paragraph. 
But euthanasia in case of dementia based on an advance directive does not only concerns 
communication, the voluntary and well considered request and a discussion about 
suffering. It is also about the future. When a patient draws an advance directive and 
states that he wants euthanasia in case of dementia, as is the case for many persons 
in The Netherlands, the person anticipates the future. The person anticipates future 
suffering, caused by dementia. However it seems almost impossible to anticipate 
future dementia and future suffering from dementia. Therefore it seems impossible 
to draft an advance directive stating a person wants euthanasia in case of dementia. 
It seems impossible to anticipate what dementia beholds for an individual, what signs 
and symptoms a person will have and if a person actually suffers from the dementia. 
On the other hand, our investigation of the accordingly applicable requirements of due 
care and the proposition on how to cope with these requirements, provide a solution 
for physicians to cope with advance directives for euthanasia in case of dementia. To 
anticipate means involving a physician early in the process, as we already stated and 
stressed earlier.
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Huntington’s Disease: the centre of a triangle of somatic, psychiatric and 
cognitive disease
Returning to the main subject of this thesis we incorporate our views upon the 
anticipation of future suffering and the applicability of advance directives into our 
findings about patients with Huntington’s Disease (HD). As mentioned by the Health 
Council and several authors HD is different compared to most other diseases, both 
somatic and neurodegenerative because patients can actually anticipate the future much 
better. Patients know what their future will be like for two reasons, their genetic status 
and their experience with a family member, even though of course every individual has 
its own course. Patients know for sure that they will have problems with cognition leading 
to dementia, and that they will someday be dependent on others for every day care, 
for most of them leading to admittance to institutionalized care. The possible suffering 
includes many different factors, both somatic, cognitive and psychiatric. For HD patients 
suffering is not only anticipated as a possibility, most patients know for certain that some 
form of suffering will happen. 
HD can be placed in the middle of a triangle of the somatic, the psychiatric and the 
cognitive aspects of disease or at the crossroad of somatic disease, psychiatric disease 
and dementia. On the other hand, literature states that HD is different, because of its 
inherited genetic cause and the extensive knowledge about disease course, but is that 
really the case? How is HD different from many other diseases? 
With HD, thinking about the future, having a say in one’s life and death, deciding when 
quality of life has reached rock-bottom levels, it is all anticipating future suffering as 
with many other diseases. When a patient suffers from a somatic disease such as cancer 
or ALS or any other disease, there is some form of suffering at that moment and the 
patient looks into the future to anticipate what suffering can be expected or feared, that 
makes the suffering unbearable. HD patients do not look at their situation from a healthy 
perspective, they are already ‘patients’ in a certain way after a genetic test. Even though 
they may not have symptoms yet, they know they will develop this diseases in due 
course. Their perspective is somewhat similar to the perspective of patients with somatic 
diseases. Patients diagnosed with a somatic disease are patients from that moment on. 
They experience life and live on with their disease and their symptoms. The perspective 
of these patients is one of living with a certain disease and sometimes adapting to a new 
way of living. HD patients know, after a genetic test, that they have to adapt to a different 
life as well. 
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Furthermore, after the diagnosis of being a gene carrier for HD, these persons already 
suffer to some extent, as can be derived from the fact that the rate of suicide is increased 
just after a confirmative test result and just after a confirmation that signs and symptoms 
of the disease are present.22-26 
This perspective of HD patients denotes a key difference between persons making an 
advance directive in case of dementia and HD patients, looking at their future, with 
knowledgeable perspectives. HD is usually mentioned as an example disease for other 
neurodegenerative diseases (dementias), but because of its many similarities with 
somatic diseases, it should both be looked at as a somatic disease and as a (form of) 
dementia.  
A similarity between dementia and HD is the factor time. Although a diagnosis 
of dementia is more difficult, based on a complex spectrum of clinical criteria, 
neuropsychological and radiologic results, after diagnosis usually several years lie ahead. 
When a patient faces reality, there is an opportunity and there is time to prepare an 
advance directive and possible euthanasia request. Response shift will always be part of 
the process of disease, but only time can tell if a patient is able to cope with the disease 
and all its aspects and if response shift occurs or if a patient decides that he can cope to 
a certain point and after that point makes a choice to end life. When there is time at the 
hands of both physician and patient, progressive cognitive decline can be followed and 
anticipated on. 
On the other hand, with time on the hands of a patient and his physician, when talking 
about wishes for the end of life with patients suffering from a neurodegenerative disease, 
leading to dementia, the question can arise to what extent patients no longer capable of 
autonomous decision making can have a say in their future, medical treatment and death. 
This questions touches the ethical debate of autonomy, precedent autonomy, former 
preferences and the value of autonomy and of preferences.12;27;28 These dilemmas have 
extensively been discussed in literature and cannot be discussed or solved in the scope of 
this general discussion. Instead we choose to stay close to the possibilities provided for 
physicians by Parliament and the solutions suggested in this thesis. Parliament decided 
that former preferences should be translated into present ones and in this thesis we 
stated that communication is the key to solving the problem of dealing with cognitive 
decline, psychiatric symptoms and signs and how to cope with response shift.
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In summary a lot can be said about autonomy and the value of autonomy. For example 
when a person decides to end his life, in literature it is postulated that because autonomy 
is valuable, it needs to be respected. This is explained twofold. One explanation is that 
autonomy is part of a person and when the person is no longer there, neither is his 
autonomy. On this grounds, euthanasia and PAS should be rejected.29 
On the other hand Parliament choose the solution that former preferences should 
be transferred and translated into present ones and people should be able to make 
their own decisions. This is based on the findings that, especially in early dementia, 
patients are able to tell about their experiences with the disease and make decisions 
accordingly.17;18;30 When dementia progresses it becomes increasingly difficult to decide 
if the moment has arrived the patient mentioned in his advance directive; a struggle 
evolves between acting according to the patient’s individual dignity and having respect 
for his (precedent) autonomy versus acting in the patient’s best and current interests 
and taking care of the patient, when mental capacities have diminished to such an extent 
that a patient is no longer able to express his wishes.12;27 Again time can be of help, to 
monitor cognitive decline and anticipate, for a patient, for a physician and for family 
members. The time can be used to talk about the experiences with the disease and the 
preferences of the patient on how to cope with the disease. Knowing these preferences 
and repeatedly talking about them provides the opportunity to respect the patient’s 
autonomy and translate his previous autonomous decision about his future into a present 
choice for medical treatment or death.
A second similarity is the probability of the absence of treatment and thus reasonable 
alternatives for euthanasia, at this moment and in the near future. Advance directives 
can be prepared and the other requirements can be accordingly applicable, including 
the extrapolating of past wishes into the present. When taking the wishes into account 
that are written down in an advance directive, the physician has knowledge about 
what suffering beholds for this individual patient. The physician must have come to the 
conclusion earlier and together with the patient and must be convinced that for the 
situation the patient is in now, no reasonable alternative exists. 
The third arm of the triangle is that of psychiatry, part of HD. Psychiatric signs and 
symptoms represent their own difficulties, with regard to a request for euthanasia or PAS. 
These aspects are discussed hereafter. 




Another key feature of HD is psychiatric symptoms and signs. The psychiatric symptoms 
and signs include a broad spectrum of characteristics, including depression, suicidality, 
irritability, apathy and anxiety. Less frequent symptoms include obsessive-compulsive 
behaviour, with rates reported up to 50%.31
The earliest case of euthanasia in a patient overwhelmed by mental suffering without an 
official somatic or psychiatric diagnosis was the case of dr. Chabot in 1994, which judicial 
ruling is still very important and up-to-date nowadays, even after the introduction of the 
‘Law on review on the ending of life on request and assisted suicide’ in 2002.32 In this case 
the Supreme Court stated that ‘suffering must be abstracted from the origin of suffering 
to such an extent that the origin does not affect the extent to which the suffering is 
experienced. This does not alter the fact that, when suffering does not arise from a 
somatic disease, it is more difficult to determine the unbearableness of the suffering to 
which no prospect of improvement exists.” 
With this ruling the Supreme Court opened a door for euthanasia and PAS in case 
of psychiatric disease and suffering from a psychiatric disease. The Supreme Court 
concluded that to call for a statutory defence suffering is independent from somatic 
disease or being in the last stages of disease. Suffering is always a subjective experience 
and irrespective of the origin has a mental dimension.32 The extent to which suffering 
from a psychiatric disease could be regarded as a reason for euthanasia or PAS presented 
problems for all parties involved during the development and draft of the law and 
afterwards, including Parliament. The minister of Health Care stated that euthanasia and 
PAS are limited to the context of medical treatment, which does not include psychiatric 
diseases.33 On the other hand, the government stated elsewhere that when a patient 
with a psychiatric disease fulfils all the requirements of due care, the law could apply to 
these patients as well.33 Looking at the way the law was constructed and formulated, the 
reasoning of the government was correct. 
The RRC’s pay extra attention to this subject in their annual reports.1 Several reasons 
for heightened precaution in case of euthanasia in psychiatry have been described. 
First there is the possible influence of the disease itself on the request. Is the request a 
voluntary and well-considered request in itself or is the request the result of symptoms 
of the disease, for example suicidality in case of a depression. Secondly, suffering from a 
mental illness can be more difficult for others to understand and to recognize (chapter 6). 
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And thirdly, the controversy and sensitivity of these problems in society or with the public 
in general.33 (page 18)
Case of a wish for euthanasia in HD in the context of psychiatric symptoms
To illustrate some these problems we describe a case of a HD patient with a wish for 
euthanasia.
Case 1
The patient is a male between 60-70 years old. He has had signs and symptoms 
of HD for several years. He talked about euthanasia with his general practitioner, 
neurologist and psychologist repeatedly in the last couple of years and made an 
advance directive. An independent second physician already visited him several 
times. He could well describe his experiences with the disease and could describe 
what suffering meant for him. Keeping his ability to leave the house whenever he 
wished, being independent and having a sense of freedom were very important 
factors for him. These factors all came together in his car and the possibility to drive 
a car. He was aware of the fact that HD in his case meant psychiatric symptoms such 
as irritability, aggression, apathy, together with chorea.
In the years that followed his wish for euthanasia became more pronounced, but 
his underlying thoughts slowly confined only to the car and the ability to drive. 
In conversations with him it seemed that the car became part of an obsessive-
convulsive thought. We are now at a moment in time where the patient still 
repeatedly talks about euthanasia with his physicians, but where it has not come to 
the point yet that the patient actually asks for euthanasia.
Because of this deteriorating ability to express himself, we wonder if this obsessive-
convulsive thought is the only part of the wish that remains, or that he is no longer 
able to express the underlying reasons and considerations for his request and what his 
suffering beholds. Thus is the wish now part of a psychiatric symptom or has he lost the 
ability to reason and express his thoughts, whilst these thoughts are still present or does 
he only remember part of his wish and know that the wish is connected to the car.
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Is the patient we see now, with his psychiatric symptoms, a new person and do we have 
to continue the physician-patient relationship with the fact that you have to take these 
thoughts seriously. Or do these thoughts arise from a psychiatric disease, obsessive-
compulsive disorder, and do we have to ignore these thoughts. We feel that if we ignore 
the thoughts, we are ignoring the patient. In somatic disease, for example, pain is a result 
of metastatic cancer, and we do not ignore the pain. Obsessive-compulsive thoughts are 
a result of HD and we should not ignore them. As the Supreme Court stated: the origin 
does not affect the extent to which the suffering is experienced.
The fact remains that it is difficult to determine if a patient with obsessive-compulsive 
thoughts or apathy still suffers. If the origin of the thoughts faded away due to dementia, 
or if cognitive deterioration is to such an extent that the content of the thoughts 
disappeared, is a patient still able to suffer? This is in line with the reasoning of The 
Health Council of The Netherlands that dementia alone is not enough ground for 
euthanasia. In literature it is also stated that patients with dementia do not actually 
suffer.33 On the other hand several other studies and practical experience show that there 
are patients with dementia who suffer from their disease.17;30 Furthermore if euthanasia 
is about anticipating future suffering, we argue that as physicians we are obligated to find 
answers to these questions. 
In order to find an answer to these questions, we have to return to the translated will of 
the patient, look at others ways of communicating with the patient and try to find out if 
the patient is still able to tell his experiences with the disease and for example still able 
to talk about his obsessive-compulsive thoughts and what lies behind these thoughts. 
We described part of the answers to these questions in chapter 6, where we conclude 
that the basis for finding these kind of answers is a longstanding physician-patient 
relationship.
Euthanasia, psychiatry and Huntington’s Disease
The RRCs conclude that when evaluating a request for euthanasia in case of a psychiatric 
disease a physician always has to ask himself if the request was well considered and 
voluntary. A psychiatric disease can affect the judgement of a patient considering his 
situation and his understanding of the disease. A decreased understanding of the disease 
can affect decision making capacity. Psychiatrists mention to experience difficulties 
with the evaluation of both the voluntariness of the request and knowing if the patient 
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really wants to die, thus if the request is well-considered. Regarding the voluntariness, 
the request can be complicated by compelling influences from outside, for example the 
experience of being a burden or a real influence from relatives or care givers. 
Secondly, the wish to die must be a result of a process of considerations resulting in only 
one possible solution, death, and not the result of a sudden ebullition. A request from 
a patient suffering from a psychiatric disease can also be complicated by compelling 
pathological influences from inside. A request can only be well considered if the patient 
is ‘free’ to make his own decisions, not influenced by thoughts or ‘assignments’. The 
key question remains if the patient put proper weight on all the relevant facts and 
circumstances over a longer period of time and can denominate all of these relevant facts 
and circumstances in light of his own illness.34 
Furthermore a psychiatrist should pay extra attention to the unbearable suffering, which 
must be understandable to a certain point. The Dutch Association of Psychiatry (NVVP) 
advises psychiatrists to take the knowledge about the personality, medical history and 
biography of the patient into account. The NVVP states that unbearable suffering is partly 
defined by the permanency of the suffering.34 Although from another perspective it 
must be emphasised that physicians must separate their own beliefs and biases from an 
objective capacity assessment process.35 The NVVP has a guideline to help psychiatrists 
with the evaluation of an euthanasia request from patients with a psychiatric disease.34
The RRC advises to consult a psychiatrist is such cases, besides an independent second 
physician. Special attention should be paid to depressive moods. Suffering from any 
disease can cause a depressed mood, but this does not always mean the patient is 
depressed. A depressed mood and depression can influence the perception of suffering. 
An independent psychiatrist can evaluate if the request is influenced by a depression 
and thus influences the well-considered and voluntary request, or if the patient has a 
depressed mood, but this does not affect the request.(1) In HD psychiatric symptoms 
include more than just depression, which is mainly the focus of the RRCs in their annual 
reports.
Several points of the NVVP guideline are relevant for HD patients and should be 
evaluated, although not all points are always applicable. For example when a patient 
shows signs of apathy and anxiety, it requires a different approach to the patient with 
a request for euthanasia. Anxiety can behold both anxiety for future suffering and 
dependence as well as more existential anxiety for the future. Both can influence the 
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request for euthanasia and should be investigated and evaluated with the patient to 
search for possible relief other than euthanasia, following the requirements of due care. 
Furthermore, for example in our case, obsessive-convulsive thoughts are part of the 
symptoms and signs of HD. Again the physician should investigate if the request is still 
well considered and voluntary.
Unbearable suffering in patients with psychiatric diseases can be difficult to determine. 
Not only because of the previously mentioned reasons, but also because psychiatric 
diseases can fluctuate in time and it is possible that spontaneous improvement occurs. 
This is not to be expected in HD, since psychiatric symptoms are part of a progressive 
disease. Furthermore, looking at the requirement of a reasonable alternative, it is 
questionable if a psychiatric treatment in case of psychiatric symptoms in a HD patient 
will lead to an acceptable improvement, in light of the just mentioned progression. 
After the ruling in the Chabot case, the Supreme court added an extra requirement in 
case of a request for euthanasia and psychiatry, namely an independent consultation of 
a psychiatrist, besides an independent second consultation of a physician. In case of a 
request from a HD patient, this will depend on the individual assessment of a patient. 
Do somatic and cognitive signs and symptoms prevail or mainly psychiatric? The answer 
to this question will determine which independent physician will be asked and if several 
other consultations will be held, such as by a psychiatrist or geriatrist. 
Future perspectives
HD is a disease that determines the course of life. Most patients know what their future 
will look like. We suspected that because of the possibilities in The Netherlands to talk 
about the end of life and to have a say in the end of life, many patients would think about 
just that. But as one physician stated during the interview, end of life wishes have always 
been present. Patients are just more open about them now, than they were earlier, when 
euthanasia and PAS were not legal yet. 
As mentioned in several chapters, knowledge about the possibilities of euthanasia and/
or PAS in HD and the use of advance directives is sometimes limited. In light of our 
exploration of the themes of the applicability of advance directives and the specific 
signs and symptoms of HD, we can come to some general or even explicit suggestions on 
how to deal with a request for euthanasia. For example should we document all wishes 
centrally, in order to be able as a physician to translate past wishes into the present 
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situation? But that does not solve the problem of communication and the possibility 
to explore the present suffering or to determine if all possible treatments have been 
proposed and tried. It also does not help to determine if the wish is consistent. 
To deal with a request for euthanasia or PAS in HD no definitive solution can be 
provided. For a patient to anticipate the future and make preparations for the future 
we, as physicians, can only act within the limits set by the law, although we are in a 
transition towards searching the boundaries of the law and placing our actions in an 
ethical perspective. In order to do this within the law, we have to make sure that every 
physician knows and more importantly understands the possibilities provided for in the 
law. Parliament provided possibilities when Parliament stated in the law that advance 
directives can be valid if the other requirements of due care are met. A physician can 
afford a certain amount of freedom, when the wishes are documented well, repeatedly 
discussed and consistent.
Our finding that HD patients in The Netherlands do think about their future and have 
wishes for the end of life, and because of their sometimes extensive knowledge about 
the future, we think that end of life wishes are also present in patients in other countries. 
Even though our research could not prove this assumption. The rate of suicide in HD is 
higher than in the general population. Is this only because of the psychiatric signs and 
symptoms of the disease or because patients want a say in their future, a say in their end 
of life? 
We suggest further research should be done to investigate the wishes of patients in other 
countries; to investigate if end of life wishes exist. Furthermore with this knowledge it 
can be possible to educate treating physicians. Because at the moment a cure is not to 
be expected in the near future and thus guiding and treating your patients may also be 
providing quality of life and quality of death. 
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This thesis reports on a study on wishes for the end of life, more specifically euthanasia 
and physician-assisted suicide, in patients with Huntington’s Disease (HD) and known 
gene carriers. 
In the introduction we report upon the development of the practice of euthanasia and 
physician-assisted suicide (PAS) in The Netherlands and upon the development of similar 
legislation in other countries (chapter 1). In The Netherlands the possibilities resulted in 
an increase in reported cases of euthanasia and PAS since 2002. Furthermore an increase 
of attention for this topic, especially for patients with dementia in advanced stages, 
resulted in the establishment of End of Life clinics. 
We explored the possibilities of euthanasia and physician-assisted suicide (PAS) in HD 
based on the Dutch Act “Termination of Life on Request and Assisted Suicide” from 
2002 (chapter 2). Since HD is a neurodegenerative disease, characterized by cognitive 
deficits leading to dementia, asking for euthanasia and PAS can be a problem for patients, 
because of the nature of the disease, the nature of suffering and the problem with the 
requirement that the request must be well-considered and voluntary. On the other hand 
following the wish of a patient can be a problem for physicians as well, because of the 
afore mentioned problems. Exploring these issues and performing a literature study 
showed that euthanasia and PAS are possible in patients with HD within the current 
boundaries of the law of 2002 in The Netherlands.
To explore if patients actually have wishes for the end of life, we interviewed patients and 
known gene-carriers for HD about their wishes and to study if participants are willing to 
talk about this topic (chapter 3). We discovered that many interviewed persons already 
had wishes for the end of life. Some of them had already talked about their wishes with 
family members or a physician, for others wishes concerned more of a feeling or a vague 
wish of what they wanted or wanted to avoid. Although our questions were not directed 
towards euthanasia and PAS specifically, most participants talked about the end of life 
and death spontaneously. The reason for thinking about the end of life and wanting to 
have a say in these stages of life and disease was in most cases the example of an affected 
parent. Not all participants were aware of the fact that a wish for euthanasia or PAS and 
an advance directive should be discussed with a physician repeatedly. Some attributed 
importance to family members and their consent, which is not a requirement of the law. 
Furthermore the scope of an advance directive was somewhat overestimated and the 
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requirement of sound professional support during the whole process of disease in light of 
the fulfillment of wishes for the end of life was underestimated. 
After our qualitative study in Chapter 3, describing important themes which are 
important for HD patients when thinking about the end of life, we further investigated 
the wishes for the end of life of patients quantitatively (chapter 4). The aim of this 
study was to find out if there were any demographic or disease characteristics which 
associated with the presence of wishes and if the content of wishes was associated with 
any of these characteristics. For this purpose we developed a questionnaire which was 
sent out to all known HD patients and gene carriers registered in the Registry database 
in the Leiden University Medical Center. We received 134 filled out questionnaires. 
Seventy-five percent of respondents answered that they have some kind of wishes for 
the end of life. Eighty-six out of 134 responded to have thoughts about euthanasia and/
or PAS. The presence of thoughts or wishes for the end of life was significantly related to 
being familiar with HD in the family, but not related to any other demographic or disease 
characteristic. Respondents with thoughts particularly directed towards euthanasia and/
or PAS were of higher education and in the earlier stages of the disease. These results 
show that it is important for every physician to be aware of the fact that HD patients think 
about the end of life and these thoughts and wishes should be discussed.
After these surveys on the thoughts, wishes and opinions of HD patients and known 
gene carriers, we also asked physicians about their role and function when talking 
and thinking about the end of life. In Chapter 5 and 6 we describe the results of 
our qualitative study amongst physicians, familiar with HD and their thoughts and 
experiences with wishes for the end of life from patients, especially euthanasia and 
PAS. Using a qualitative method we wished to identify themes that are important for a 
physician when talking about (wishes for) the end of life with HD patients. In chapter 
5 we argued that a physician has a legal, professional and moral responsibility to talk 
about the end of life and wishes for the end of life with patients. A physician has to 
play an active role in this process and especially the advance directive should have a 
more central role in the communication between physician and patient. In order to 
achieve a more active role of physicians towards the subject of advance care planning 
and advance directives, we proposed the use of a letter of intent. Using this letter 
promotes active participation of a physician in the process. Especially in the case of HD, 
where as mentioned earlier, cognitive decline is a key symptom of the disease, active 
participation from a physician, using a letter of intent as the basis of communication, 
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can make the process of thinking and fulfilling wishes for the end of life, in light of a 
neurodegenerative disease, easier. 
In chapter 6 we further studied the evaluation of a request for euthanasia and/or PAS 
from the point of view of a physician. We identified three patterns of evaluation of a 
request, which varied according to the specialty of a physician. These patterns were 
based on different evaluation and dealing with cognitive decline, psychiatric signs and 
symptoms of the disease and on how to cope with response shift. The evaluation and 
handling of these themes in light of advance care planning was based upon a good and 
longstanding physician-patient relationship. Looking at the requirements of the Dutch law 
of 2002, the requirement of suffering came forward as a requirement that was judged 
upon differently, depending upon the specialty of each physician. Looking more closely 
at these themes, loss of decision making capacities, psychiatric signs and symptoms and 
response shift are themes that every physician has to cope with when talking about 
advance care planning with a patient. This does not only apply to The Netherlands, 
where euthanasia and PAS are legal, but apply to all physicians when decisions for the 
end of life must be made. A firm and possibly longstanding physician-patient relationship 
with knowledge of the patients past, present and future values, goals and wishes is of 
importance for all physicians.  
To support our conclusions of chapter 6 we extended our study towards physicians in 
other countries in Europe. To find out whether these physicians also receive questions 
and wishes for the end of life and if advance care planning is part of their treatment 
and guidance of HD patients, we sent out a questionnaire to more than 500 physicians 
in Europe, all participants in the European Huntington’s Disease Network. The results 
of this study are described in chapter 7. Unfortunately we only received a response 
rate of around 10%, which is not enough to draw any conclusion. Nevertheless, half 
of the respondents answered that their HD patients express wishes for the end of life. 
Opinions, upon the options for patients to have a say in their end of life, varied amongst 
the respondents. Some respondents indicated that the law in their country provided 
enough options for palliative care, or their personal opinion ensured that enough options 
to take care of their patients are available. Others responded that they would like to see 
options expanded, because wishes exist and patients seek other ways to find a solution 
for their wishes, for example suicide. Even though we could not draw any conclusions 
from this study, we can conclude that wishes for the end of life exist in HD patients in 
other European countries as well, even when euthanasia and/or PAS are against the law. 
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From this finding we draw the conclusion that physicians should prepare themselves for 
conversation of this nature with their patients in the near future. 
The main results of our study are summarized in chapter 8. Thereafter, several legal 
and methodological issues with the Dutch “Law on Termination of Life on Request and 
Assisted Suicide” of 2002 are discussed, especially the difficulty with the second article, 
paragraph 2, stating that advance directives are ‘accordingly applicable’ in a request 
for euthanasia and/or PAS when all other requirements of the law are followed. In The 
Netherlands currently there is a debate in the media, in politics and in the general public 
opinion about the possibilities of euthanasia and/or PAS in case of a patient suffering 
from dementia or suffering from a psychiatric disease. Recent rulings of the Review 
Committees of Euthanasia are discussed, especially when they concern HD, and the 
theme of psychiatric symptoms and signs is further elaborated. 
Based on this study we conclude that euthanasia and PAS are possible in case of a patient 
suffering from Huntington’s Disease, also based on an advance directive. Requirements 
in order to make this possible are a sound and possibly longstanding physician-patient 
relationship. Secondly a thorough knowledge of the requirements of due care and 
the applicability of advance directives is necessary, for patients as well as physicians. 
Physicians and patients should both be educated upon the possibilities within the law.  




Dit proefschrift beschrijft de resultaten van een studie naar levenseindewensen, meer 
specifiek euthanasie en hulp bij zelfdoding, bij bekende gendragers en patiënten met de 
ziekte van Huntington (HD).
In de Introductie beschrijven we de ontwikkeling in regelgeving en de praktijk van 
euthanasie en hulp bij zelfdoding in Nederland en beschrijven we de ontwikkeling van 
soortgelijke wetgeving in andere landen (Hoofdstuk 1). De mogelijkheden die de wet 
bood op het gebied van euthanasie en hulp bij zelfdoding resulteerden in een toename 
van de rapportage van verleende euthanasie en hulp bij zelfdoding vanaf 2002. Daarnaast 
zorgde een toegenomen aandacht voor dit onderwerp, in het bijzonder bij patiënten met 
dementie in een gevorderd stadium, voor de oprichting van de Levenseinde-klinieken. 
We verkenden de mogelijkheden van euthanasie en hulp bij zelfdoding bij de ziekte 
van Huntington gebaseerd op de Wet Toetsing Levensbeëindiging op Verzoek en 
Hulp bij Zelfdoding uit 2002 in Hoofdstuk 2. Omdat de ziekte van Huntington een 
neurodegeneratieve ziekte is, gekenmerkt door cognitieve stoornissen die tot dementie 
leiden, kan vragen naar levensbeëindiging door euthanasie of hulp bij zelfdoding een 
probleem zijn. Dit vanwege de aard van de ziekte, de aard van het lijden en het probleem 
dat een verzoek om levensbeëindiging weloverwogen en vrijwillig moet worden gedaan. 
Anderzijds kan het voldoen aan de wens van een patiënt ook voor een arts een probleem 
zijn, vanwege de zojuist geschetste problemen. Na bestudering van de literatuur en het 
exploreren van de problemen komen we tot de conclusie dat euthanasie en hulp bij 
zelfdoding bij patiënten met de ziekte van Huntington in Nederland mogelijk zijn binnen 
de grenzen van de wet uit 2002.
Om te verkennen of patiënten ook daadwerkelijk wensen hebben voor het levenseinde, 
hebben we veertien patiënten en bekende gendragers voor de ziekte van Huntington 
geïnterviewd en gevraagd naar hun wensen. Daarnaast konden we met deze interviews 
onderzoeken of patiënten bereid zijn over dit onderwerp te spreken (Hoofdstuk 3). Uit 
de interviews konden we opmaken dat veel van de geïnterviewden al hadden nagedacht 
over het levenseinde. Enkele van hen hadden reeds met familie of een arts over hun 
wensen gesproken. Voor anderen bestonden de wensen meer uit een gevoel of nog niet 
expliciete gedachten of een latente wens over wat ze wilden of juist wilden vermijden. 
Hoewel onze vragen niet specifiek gericht waren op euthanasie en hulp bij zelfdoding, 
spraken de meeste deelnemers uit zichzelf over het levenseinde en de dood. Voor de 
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meeste deelnemers was het voorbeeld van een aangedane ouder de reden om over het 
einde van het leven na te denken. Niet alle deelnemers waren zich bewust van het feit dat 
een wens voor euthanasie of hulp bij zelfdoding en een wilsverklaring herhaaldelijk met 
een arts moeten worden besproken. Sommigen gaven aan dat familieleden belangrijk zijn 
en dat zij moeten instemmen met de wensen, terwijl dit geen vereiste is volgens de wet. 
Daarnaast werd de reikwijdte van een wilsverklaring overschat en de centrale rol van de 
arts, in het proces van het uiten van wensen en met name het tegemoet komen aan de 
levenseindewensen, onderschat.
Vervolgens hebben we de wensen voor het levenseinde van patiënten kwalitatief 
onderzocht (Hoofdstuk 4). Het doel van dit onderzoek was om uit te zoeken of er 
demografische of patiëntgebonden karakteristieken zijn die geassocieerd zijn met de 
aanwezigheid van wensen. Om dit te onderzoeken hebben we een vragenlijst ontwikkeld 
en verstuurd naar 242 bekende HD-patiënten en gendragers die geregistreerd staan in 
de Registry database van het Leids Universitair Medisch Centrum. We ontvingen 134 
ingevulde vragenlijsten retour. Vijfenzeventig procent (n=101) van de respondenten 
gaven aan dat zij wensen hadden met betrekking tot het levenseinde in enige vorm. 
Vierenzestig procent (n=86) gaf aan dat hun gedachten ook uitgaan naar euthanasie of 
hulp bij zelfdoding. De aanwezigheid van wensen of gedachten voor het levenseinde was 
significant geassocieerd met het feit dat de respondent bekend was met de ziekte van 
Huntington omdat familieleden de ziekte hebben of hadden, maar niet geassocieerd met 
enig ander kenmerk (demografisch of ziektegerelateerd). Respondenten met gedachten 
of wensen die expliciet gericht waren op euthanasie of hulp bij zelfdoding waren hoger 
opgeleid en in de vroegere fasen van de ziekte. Deze resultaten laten zien dat van te 
voren niet te bepalen is wie wensen heeft en dat het dus belangrijk is voor een arts om te 
vragen naar wensen en deze te bespreken.
Na onze onderzoeken onder patiënten en bekende gendragers hebben we ook artsen 
gevraagd naar hun rol en functie wanneer ze met patiënten nadenken en spreken over 
het levenseinde. Hoofdstukken 5 en 6 beschrijven de resultaten van ons kwalitatief 
onderzoek onder artsen, die bekend zijn met de ziekte van Huntington, over hun 
gedachten en ervaringen met levenseindewensen van hun patiënten, specifiek met 
betrekking tot euthanasie en hulp bij zelfdoding. Door te kiezen voor een kwalitatieve 
onderzoeksmethode wilden we thema’s identificeren die belangrijk zijn voor een 
arts wanneer hij spreekt over (wensen voor) het levenseinde met HD-patiënten. In 
Hoofdstuk 5 beargumenteren we dat een arts een juridische, professionele en morele 
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verantwoordelijkheid heeft om over het levenseinde te praten met patiënten. Een 
arts moet een actieve rol spelen in dit proces en met name de wilsverklaring zou een 
meer centrale rol moeten hebben in de communicatie tussen arts en patiënt. Om deze 
actieve rol te benadrukken en ondersteunen stellen wij voor dat arts en patiënt een 
intentieverklaring opstellen. Zeker in het geval van de ziekte van Huntington, waarbij zoals 
eerder gezegd cognitieve achteruitgang een kernsymptoom is, kan actieve participatie 
van de arts, met de intentieverklaring als startpunt voor de communicatie, het proces van 
denken over, invulling geven aan en uitvoeren van de levenseindewensen, in het kader 
van een neurodegeneratieve ziekte, gemakkelijker maken. 
In Hoofdstuk 6 hebben we de beoordeling en evaluatie van een verzoek voor euthanasie 
of hulp bij zelfdoding verder bestudeerd vanuit het gezichtspunt van de arts. We konden 
drie patronen identificeren wanneer een verzoek wordt beoordeeld, die varieerden 
al naar gelang de specialisatie van de arts. Deze patronen zijn gebaseerd op een 
verschillende evaluatie van de cognitieve achteruitgang, psychiatrische symptomen van 
de ziekte en hoe om te gaan met ‘response shift’. De evaluatie en beoordeling van deze 
patronen in het licht van het maken van keuzen over het levenseinde was gebaseerd 
op een goede en langdurige arts-patiënt-relatie. Wanneer we kijken naar de vereisten 
van de Wet Toetsing Levensbeëindiging en Hulp bij Zelfdoding uit 2002 zien we dat het 
vereiste van ondraaglijk lijden naar voren kwam als een vereiste dat verschillend wordt 
geïnterpreteerd, afhankelijk van het specialisme van de arts. Kijkend in meer detail naar 
deze thema’s zien we dat het verlies van wilsbekwaamheid, psychiatrische symptomen 
en ‘response shift’ onderwerpen zijn waarmee elke arts te maken krijgt als hij met 
HD-patiënten praat over hun wensen voor het levenseinde. Dit geldt niet alleen voor 
de Nederlandse situatie, maar voor alle artsen van HD-patiënten wanneer over het 
levenseinde gedacht en gesproken wordt en beslissingen voor het einde van het leven 
genomen moeten worden. 
Om onze conclusies uit Hoofdstuk 6 te ondersteunen hebben we ons onderzoek 
uitgebreid naar artsen in andere landen van Europa. Om uit te vinden of deze artsen 
ook vragen krijgen over het levenseinde en/of nadenken over en beslissingen nemen 
over wensen voor het levenseinde onderdeel is van hun behandeling en begeleiding van 
patiënten met de ziekte van Huntington, hebben we vragenlijsten gestuurd naar meer 
dan 500 artsen die deelnemen aan het European Huntington’s Disease Network (EHDN). 
De resultaten van dit onderzoek worden beschreven in Hoofdstuk 7. Helaas is slechts 
ongeveer 10% van de vragenlijsten geretourneerd en dit is niet voldoende om conclusies 
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uit te trekken. Desondanks gaf de helft van de respondenten aan dat hun patiënten met 
de ziekte van Huntington levenseindewensen uiten. Meningen over de mogelijkheden die 
een patiënt heeft om zeggenschap te hebben over zijn levenseinde, varieerden. Sommige 
respondenten gaven aan dat de juridische mogelijkheden in hun land voldoende 
opties boden voor palliatieve zorg of hun persoonlijke benadering zorgde ervoor dat er 
voldoende opties waren om voor hun patiënten te zorgen. Anderen antwoordden dat 
zij graag zouden zien dat de mogelijkheden verruimd zouden worden, omdat de wensen 
nu eenmaal aanwezig zijn en patiënten andere wegen zoeken om hun wens in vervulling 
te laten gaan, bijvoorbeeld door suïcide. Ondanks het feit dat we geen harde conclusies 
konden trekken uit dit onderzoek, kunnen we wel stellen dat levenseindewensen ook 
aanwezig zijn bij patiënten met de ziekte van Huntington in andere Europese landen, zelfs 
wanneer euthanasie en hulp bij zelfdoding niet toegestaan zijn. 
De belangrijkste bevindingen van ons onderzoek zijn samengevat in Hoofdstuk 8. 
Daarna worden enkele methodologische aandachtspunten van de Wet Toetsing 
Levensbeëindiging op verzoek en Hulp bij Zelfdoding uit 2002 besproken, met name 
de moeilijkheden met het tweede artikel, lid 2, waarin wordt gesteld dat schriftelijke 
wilsverklaringen van overeenkomstige toepassing zijn bij een verzoek om euthanasie 
of hulp bij zelfdoding wanneer alle andere vereisten van de wet worden gevolgd. 
Op dit moment is er in Nederland een debat gaande in de media, politiek en in de 
samenleving over de mogelijkheden van euthanasie of hulp bij zelfdoding wanneer 
een patiënt dementeert of een psychiatrische ziekte heeft. Recente uitspraken van de 
Regionale Toetsingscommissies Euthanasie worden besproken, met name wanneer zij 
over patiënten met de ziekte van Huntington gaan, en het thema van psychiatrische 
symptomen wordt in dit hoofdstuk verder uitgewerkt.  
Gebaseerd op dit onderzoek concluderen wij dat euthanasie en hulp bij zelfdoding in 
Nederland binnen de kaders van de huidige wet- en regelgeving mogelijk zijn bij patiënten 
met de ziekte van Huntington, ook op basis van een schriftelijke wilsverklaring. Een 
vereiste om dit mogelijk te maken zijn een goede en indien mogelijk langer bestaande 
arts-patiënt-relatie. Daarnaast is een grondige kennis van de vereisten van de wet en de 
toepasbaarheid van de wilsverklaring noodzakelijk, zowel voor artsen als voor patiënten. 
Zowel artsen als patiënten zouden verder geschoold en/of voorgelicht moeten worden 
over de mogelijkheden die de wet hun biedt. 
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Topic lisT inTerviews meT arTsen
Gedachten over euthanasie
Gedachten over euthanasie bij Huntington
Speelt het feit dat patiënten cognitief achteruit gaan een rol bij deze gedachten
Ervaringen met wilsverklaringen bij Huntington
•	 wanneer bespreek je dat met patiënten
•	 hoe bespreek je dat
•	 met wie bespreek je dat (patiënten/familie)
Wanneer komt het onderwerp euthanasie bij patiënten/familie naar voren 
•	 wat zijn de omstandigheden waaronder het onderwerp naar voren komt
Ervaringen met euthanasie bij Huntington
Is er veel verschil tussen wilsverklaringen en euthanasie in de praktijk
Beperkingen in het uitvoeren van wilsverklaringen bij Huntington
Beperkingen in het uitvoeren van euthanasie bij Huntington
Conflicten met familie/patiënten
Hoe gaat het team verder met deze vragen om, indien patiënt in een instelling verblijft
Zien artsen mogelijkheden om de zorg op dit vlak te verbeteren
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Topic lisT inTerviews meT paTiënTen/ dragers van 
de genmuTaTie/ parTners
Sociale omstandigheden/werk
Ervaringen in de familie
Gedachten over euthanasie
Gedachten over wilsverklaringen
•	 wat zijn de mogelijkheden
•	 wat moet daar in staan
•	 wanneer komen de gedachten naar voren
Gesprekken met familie/partner over wilsverklaring of euthanasie
Ervaringen met wilsverklaringen in het verleden bij familie
Aanwezigheid van wilsverklaring en inhoud hiervan
Met wie is de wilsverklaring besproken, hoe vaak
Veranderingen in de gedachten over wilsverklaringen/euthanasie in de laatste jaren
Verbeteringen van zorg of begeleiding door artsen op het gebied van euthanasie/
wilsverklaringen 
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Questionnaire regarding end-of-life Questions in 
paTienTs wiTh hunTingTon’s disease
This questionnaire handles the subject of end-of-life wishes in patients with Huntington’s 
disease (HD). In this study we want to investigate if physicians receive questions regarding 
the end of life from their HD patients, what kind of questions and how physicians handle 
and cope with these questions.
The questionnaire was drawn up after qualitative research with physicians familiar with 
HD and the treatment of HD patients. 
We ask you to fill in this questionnaire about patient’s you have treated with Huntington’s 
disease (HD) or patients with HD you have been in contact with.
Your answers will be coded and analysed confidential. No answers will be traceable to 
you.
Instructions on how to fill in the questionnaire: 
Usually we ask you to pick one answer of the options provided. If there is a different 
possibility, it will be indicated. There are no correct of false answers.
When answering a multiple choice questionnaire it is not always possible to find the 
correct nuance in the answers given. If possible pick the answer that is closest to your 
own or otherwise please use the ‘other’ option or the last page of the questionnaire to 
exemplify your answers. We kindly ask you to write down the number of the question 
when making extra remarks on the last page. 
We thank you in advance for your cooperation.








d. Geriatrist or physician of the elderly





e. > 30 years
3. What is your gender?
a. Male
b. Female





e. > 60 years
5. In what country do you practice as a physician?
6. Are you religious?
a. Yes
b. No
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8. How important is religion to you?
a. Very important
b. Reasonably important
c. Not important/ not unimportant
d. Reasonably unimportant
e. Very unimportant
general questions about end-of-life wishes




10. Are end of life wishes concerning for example do not resuscitate, treatment 
limitations, rejection of fluid or food etc valid in your country?
a. Yes
b. No	
11. Sometimes there is a difference between official and how things are handled semi-
official or off the record, considering wishes regarding the end of life. Are you familiar 
with a situation where reality of handling was different to the official requirements? 
If yes, could you describe the situation?
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13. Are advance directives concerning other wishes regarding the end of life, for example 




14. What kind of advance directive? (multiple answers possible)
a. Do-not-resuscitate orders
b. Other treatment limitations, other than DNR
c. Wish for euthanasia
d. Concerning a wish to live and treatment order
e. Concerning the appointment of a representative
f. Other, …
general questions about Hd patients 
15. Approximately how many patients with HD do you treat at the moment?
16. Approximately how many patients with HD have you treated in the past?
17. What is the main cause of death for most HD patients in your country?
a. Pneumonia or other infection
b. Suicide
c. After stop taking food and fluids
d. Medical condition other than HD 
e. Other, … 
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18. Where do most HD patients die in your country?
a. At home
b. In a nursing home
c. In the hospital
d. Hospice 
Questions concerning end-of-life wishes in Hd




Please take the last patient you had with end of life wishes in mind.
20. How did you get familiar with these wishes?
a. I asked the patient about these wishes
b. The patient talked to me about these wishes
c.	 Family	members	talked	to	me	about	these	wishes
d. Professional care givers talked to me about the wishes
21. What was the reason for this HD patient to have end of life wishes?
a. After seeing a family member with the disease
b.	 Fear	for	future	suffering
c. Signs and/or symptoms of the disease present
d. Staying in control of future own life
e. Other, … 
22. At	what	time	were	the	wishes	talked	about?
a. When in the phase of being at risk, but not tested
b. When in the phase of being a gene-carrier, without symptoms
c. When in the early phase of the disease, with only slight symptoms
d. When in more advanced stages of the disease
e. Other




a. Wishes regarding place to live when they become dependent
b. Wishes regarding treatment of infections
c. Wishes regarding administration of fluid and food
d. Wishes regarding admittance to a hospital
e. Wishes regarding admittance to a nursing home
f. Wishes regarding death, euthanasia, physician assisted suicide





25. What kind of role (please describe)
26. What is your reaction if a patient presents himself with a wish regarding the end of 
life? (please describe)
Response shift turned out to be a concern in our focus group. Response shift means 
adapting to the situation or deviating from anticipatory beliefs.
27. Do or did you encounter response shift? 
a. No
b. Yes,	in	what	way?
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Questions about advance directives concerning end-of-life wishes
28. Do HD patients or gene carriers ever present an advance directive to you?
a. Yes
b. No	
Please take the last advance directive in mind.
29. How did you get familiar with the advance directive?
a. I asked the patient about the presence of an advance directive
b. The patient told me about his advance directive
c.	 Family	members	told	me	about	the	presence	of	an	advance	directive
d. Professional care givers told me about the presence of an advance directive 
30. When was the advance directive drawn up?
a. When in the phase of being at risk, but not tested
b. When in the phase of being a gene-carrier, without symptoms
c. When in the early phase of the disease, with only slight symptoms
d. When in more advanced stages of the disease
e. Other
31. What was the content of advance directives? 
a. Do-not-resuscitate orders
b. Other treatment limitations, other than DNR
c. Wish for euthanasia
d. Concerning a wish to live and treatment order
e. Concerning the appointment of a representative
f. Other, …
32. Do you think it is helpful for a HD patient to draw an advance directive?
a. Yes,	why
b. No,	why	not	
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33. What is your reaction if a patient presents himself with an advance directive 
consisting of a wish regarding the end of life? (please describe)
34. What happened with the advance directive and the wish described in the advance 
directive? (please describe)
35. Were any actions taken? If yes please describe
36. Do you encounter response shift with respect to advance directives?
a. Yes	(please	answer	questions	36)
b. No	(please	go	to	question	37)
37. How do you handle response shift with regard to an advance directive? (please 
describe)
Huntington’s disease is also characterized by cognitive deterioration.




39. How do you cope with an advance directives and cognitive deterioration? (please 
describe)
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40. Wishes regarding the end of life can be an intensively discussed subject. Physicians 
are searching for a way to handle these subjects, opinions have to be formed. Did 
your opinion change regarding end-of-life wishes in HD while practicing as a doctor?
a. Yes,	in	what	way
b. No
41. What is your opinion about the present options a patient has regarding end of life 
wishes and the possibility of having these wishes executed?
42. What would be your wish regarding end of life wishes and the possibilities for 
patients to choose their end of life? 
Thank you for your cooperation
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vragenlijsT: ‘Beslissingen en wensen rondom 
heT levenseinde Bij mensen meT de ziekTe van 
Huntington of in de premanifeste fase van de 
ziekTe.’
Deze vragenlijst gaat over de vragen rondom het levenseinde van patiënten met de ziekte 
van Huntington of in de premanifeste fase van de ziekte. 
We kijken in deze studie naar vragen die kunnen spelen bij patiënten en hun verzorgers/
partners en hun gedachten en eventuele weg naar het zoeken van een antwoord 
of verwoorden van het antwoord. Door middel van deze vragenlijst willen wij meer 
inzicht krijgen in de wensen van patiënten en hun verzorgers/partners als het gaat om 
beslissingen en wensen rondom het levenseinde.
In deze vragenlijst komen de volgende onderwerpen aan bod:
 Algemene vragen over u
 Sociaal functioneren en kwaliteit van leven 
 Gezondheidszorg
 Verblijfsplaats
 Wensen rondom het levenseinde
Instructies voor het invullen:
Bij de meeste vragen is het de bedoeling dat u één antwoord invult. Als er meer dan 
één antwoord ingevuld kan worden, staat dat aangegeven. Er zijn geen goede of foute 
antwoorden. De vragenlijst bestaat uit 39 vragen.
Aangezien de vragenlijst voornamelijk uit meerkeuzevragen bestaat, kan het zijn dat het 
antwoord dat u zou willen geven er niet precies bij staat. In dat geval kunt u het antwoord 
aankruisen dat het meest de werkelijkheid benaderd of de mogelijkheid `anders` 
aankruisen en daar het antwoord invullen. 
Indien u een vraag echt niet kunt of wilt beantwoorden, kunt u de vraag open laten.
Aan het einde van de vragenlijst is ruimte voor toelichting. Wij verzoeken u vriendelijk de 
toelichting per vraagnummer te noteren.
Bij voorbaat dank voor uw medewerking
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datum van invullen: 
algemene vragen over u











4. Beschouwt u zich als behorend tot een godsdienstige groepering of voelt u zich 
verbonden met een bepaalde levensbeschouwelijke overtuiging?
a. Nee
b. Ja,	namelijk…
i. Ik ben katholiek
ii. Ik ben hervormd
iii. Ik ben gereformeerd
iv. Ik ben islamitisch




c. Niet belangrijk/ niet onbelangrijk
d. Onbelangrijk
e. Helemaal onbelangrijk






c. Lager beroeps onderwijs (VMBO, LTS, huishoudschool)
d. Middelbaar algemeen onderwijs (MULO, MAVO, VMBO-t)
e. Middelbaar beroeps onderwijs (MBO, MTS)
f. Voortgezet algemeen onderwijs (HAVO, HBS, MMS, VWO)












sociaal functioneren en kwaliteit van leven
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f. Nee, ik ben ontslagen en zit in de WW
g. Nee, dat lukt mij niet meer, ik zit in de WAO/WIA/ziektewet
h. Nee, ik heb nooit gewerkt.
12. Hoe schat u uw kwaliteit van leven in de afgelopen periode?
	 1    2    3    4    5    6    7    8    9
Erg	slecht	 	 	  						 Neutraal	 	 	   	Uitstekend
Weet niet
gezondheidszorg
13. Met welke zorgverleners heeft u tijdens uw ziekte de afgelopen periode te maken 
gehad?
a. Huisarts
b. Arts in verpleeghuis
c. Neuroloog
d. Andere medisch specialist
e. Psycholoog/maatschappelijk werker







m. Anders, namelijk ...









e. Anders, namelijk ...
15. Wanneer was de laatste verhuizing? (geef indien mogelijk maand en jaar aan) 
...
16. Kunt u aangeven wat de reden was van de laatste verhuizing? (meer antwoorden 
mogelijk)
a. Uit voorzorg voor eventuele latere problemen
b. Ik had meer verzorging nodig
c. Ik had medische behandeling nodig
d. Het was mijn wens
e. Het was de wens van mijn belangrijkste naasten 
f. Anders, namelijk ...
Wensen rondom het levenseinde
17. Is de ziekte onderwerp van gesprek tussen u en uw familie/gezin?




iv. Ongeveer 1x per half jaar
v. Ongeveer 1x per jaar
vi. Minder 
b. Nee 
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d. Anders, namelijk ...
19. Sprak u ooit met een van uw ouders over de ziekte, het beloop van de ziekte? 
a. Nooit
b. Zelden
c. Af en toe
d. Regelmatig
e. Vaak 









21. Kunt u aangeven wat de reden is van het nadenken over uw wensen rondom het 
levenseinde? (meerdere antwoorden mogelijk)
a. Een van mijn ouders was ziek, ik heb het meegemaakt en wil dat niet voor 
mezelf
b. Angst voor de toekomst 
c. Lichamelijke aftakeling
d. Ik wil niet afhankelijk zijn
e. Niet meer kunnen communiceren met anderen
f. Ik wil de controle behouden
g. Het verlies van persoonlijke waardigheid, ontluistering
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h. Ik wil niet in een verpleeghuis opgenomen worden
i. Ik weet dat het einde komt, dan kan ik er maar beter nu al over nadenken.
22. Zou u later sondevoeding willen?
a.	 Ja
b. Nee
23. Zou u later opgenomen willen worden in een verpleeghuis
a.	 Ja
b. Nee
24. Denkt u wel eens na over euthanasie of hulp bij zelfdoding?
a.	 Ja
b. Nee




26. Hebt u wel eens met uw huisarts gesproken over wensen rondom het levenseinde?
a.	 Ja
b. Nee
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28. Als u nog niet met uw huisarts heeft gesproken over uw wensen, wat is hiervoor de 
reden?
a. Ik ben er nog niet aan toe
b. Ik zie er tegen op, ik vind het eng om hierover te beginnen
c. Ik stel het steeds uit, het komt er gewoon niet van.
d. Ik heb geen wensen, ik neem het leven zoals het komt.
e. Ik voel met bezwaard dit onderwerp met mijn huisarts te bespreken
f. Mijn huisarts is gelovig, dus ik denk dat hij negatief zal reageren.
g. Een eerdere reactie van mijn huisarts doet mij vermoeden dat hij negatief zal 
reageren
h. Ik heb nauwelijks contact met mijn huisarts, dus ben hiervoor niet bij hem/
haar langs geweest.
i. Mijn huisarts weet erg weinig van de ziekte. Daarom ben ik zeker nog niet 
over mijn wensen begonnen.
29. Zijn uw wensen veranderd in de afgelopen jaren?
a. Nee, de wensen zijn niet veranderd
b.	 Ja
c. Niet van toepassing
30. Kunt u aangeven wat de reden was van de verandering van de wensen?
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31. Kunt u aangeven hoe de wensen veranderd zijn? (wat waren ze eerst en wat zijn ze 
nu?)
32. Hebt u een wilsverklaring?
a.	 Ja	 	(ga	verder	met	vraag	33)
b. Nee  (dit is de laatste vraag, ga zo nodig naar de toelichting)




d. Niet reanimeren verklaring
e. Levenswensverklaring
f. Anders, namelijk ...





35. Bent u lid van de Nederlandse Vereniging voor vrijwillig levenseinde (NVVE)?
a.	 Ja
b. Nee 
Appendix_Suzanne_zonderuitvullen.indd   163 17-9-2014   8:51:16
Appendix
164
36. Hebt u deze wilsverklaring recent besproken met uw partner/gezin/familie?
a.	 Ja
b. Nee 
37. hoe vaak bespreekt u deze verklaring met uw partner/gezin of familie?
a. Ik heb hem alleen besproken toen ik hem maakte
b. Ik bespreek hem ongeveer 1x per jaar
c. Ik bespreek de verklaring ongeveer 2x per jaar
d. Ik bespreek de verklaring vaker, namelijk
38. Hebt u deze wilsverklaring recent besproken met uw huisarts of specialist? 
a.	 Ja
b. Nee 
39. Hoe vaak bespreekt u deze verklaring met uw huisarts?
a. Ik heb de verklaring alleen besproken toen ik hem maakte
b. Ik bespreek de verklaring ongeveer 1x per jaar
c. Ik bespreek de verklaring ongeveer 2x per jaar
d. Ik bespreek de verklaring vaker, namelijk ...
Dank voor het invullen van de vragenlijst.
Graag verzoeken wij u de vragenlijst in de bijgestuurde envelop terug te sturen.
Mw	mr	drs	S.J.	Booij	 	 	 	 	 Prof	dr	R.A.C.	Roos	
Ruimte voor toelichting op bovenstaande antwoorden
(wilt u bij de toelichting het nummer van de vraag noteren?)
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Mijn dank gaat uit naar allen die hebben meegewerkt aan de totstandkoming van dit 
proefschrift, in het bijzonder de patiënten die hebben toegestemd in een interview of 
die de tijd en energie hebben gevonden voor het beantwoorden van de vragen uit de 
vragenlijst over dit moeilijke, soms confronterende en emotionele onderwerp. Ook dank 
ik de collegae die openhartig met mij spraken over hun ervaringen, meningen, wensen en 
gedachten.
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Suzanne José Booij werd op 10 mei 1980 geboren in Delft. Na het cum laude behalen 
van het gymnasiumdiploma aan het Westland College te Naaldwijk in 1998, studeerde 
zij Geneeskunde en Nederlands Recht aan de Universiteit Leiden. Tijdens haar studie liep 
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te Amsterdam. De wetenschappelijke stage van de studie Geneeskunde en de 
afstudeerscriptie voor Nederlands Recht was een gecombineerd traject, in samenwerking 
met de afdeling Transplantatiechirurgie en Pathologie van het Erasmus MC te Rotterdam, 
afdeling Burgerlijk Recht van de Rijksuniversiteit Leiden en de sectie Ethiek en Recht van 
de Gezondheidszorg van het LUMC te Leiden, onder leiding van prof mr J.H. Nieuwenhuis, 
prof mr dr D.P. Engberts, prof dr H.W. Tilanus en drs P. Zondervan. Op 24 november 2004 
behaalde zij haar doctoraalexamen in zowel het Nederlands Recht als in de Geneeskunde. 
Op 26 november 2006 behaalde zij haar artsenbul. Aansluitend startte zij als ANIOS 
Neurologie in het LUMC en per 1 juli 2007 als AIOS met prof dr R.A.C. Roos als opleider. 
Tijdens haar opleiding was zij actief als bestuurslid van de LAD, de Landelijke vereniging 
voor Artsen in Dienstverband, en bestuurslid en voorzitter van de LVAG, de Landelijke 
Vereniging voor AIOS. Namens de LVAG nam zij in 2010 deel aan de Stuurgroep Evaluatie 
Opleidingsfonds van het ministerie van VWS. 
In 2011 startte zij met haar promotieonderzoek naar wensen voor het levenseinde bij 
patiënten met de ziekte van Huntington, resulterend in dit proefschrift. In september 
2013 rondde zij de opleiding tot neuroloog af. Zij werkt sinds 1 oktober 2013 als 
neuroloog in het Canisius Wilhelmina Ziekenhuis te Nijmegen.
Suzanne is getrouwd met Tijmen Augustijn en woont in Oegstgeest.   
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